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SUMMARY 
 
A significant part of this dissertation has been published (see list of publications). Work 
described in this thesis includes domino twofold Heck / 6-electrocyclization reactions of 
2,3-dibromobenzofuran and 2,3,5-tribromobenzofuran and regioselective Suzuki-Miyaura 
cross-coupling reactions of brominated benzofurans and 2,3-dibromoindenone.  
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1   Overview 
 
1.1   Domino Twofold Heck / 6-Electrocyclization Reaction  
 
In 1987, Armin de Meijere and co-workers reported the Heck-type vinylation of 1,2,9,10-
tetrabromo[2.2]paracyclophanedienes 1 with subsequent thermal electrocyclization and 
aromatization to give benzo-annulated [2.2]paracyclophanes 3 (Scheme 1).1  
 
Br
Br
Br
Br
R
R
R
R
R
R
R
R
R
i ii
1 2 (32-50 %) 3 (12-45 %)
R = H, SiMe3, CO2Me, Ph, 4-FPh  
 
Scheme 1. Reagents and Conditions: (i) Pd(OAc)2, Bu4NBr, K2CO3 / NaHCO3, DMF,    
heat (40-100 °C); (ii) Pd/C (+O2) or S8, xylene, 150 °C 
 
In 1990, the same group again reported twofold Heck reactions of vicinal 1,2-
dibromocycloalkenes 4 to synthesize (E,Z,E)-l,3,5-hexatrienes 5 in fair to high yields (15-
69 %). Thermal electrocyclization in anaerobic conditions provided 1,3-cyclohexadienes 6 
(Scheme 2).2,3 
 
(n)
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R
(n)
R
R (n)
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4 5 (15-69 %) 6 (50-90 %)  
 
Scheme 2. Reagents and Conditions: (i) Pd(OAc)2, PPh3, NEt3, DMF, heat (90-100 °C); 
(ii) xylene or (n-Bu2O), 140-150 °C, inert conditions 
3 
 3 
 
This research group used a variety of starting materials and reaction conditions for the 
synthesis of (E,Z,E)-1,3,5-hexatrienes, such as the Wittig reaction and Heck-type 
reactions (Scheme 3).4 Heating of the reaction mixtures at 130-150 °C in oxygen-free 
xylene or di-n-butyl ether resulted in electrocyclization of the (E,Z,E)-1,3,5-hexatrienes. As 
these electrocyclizations were done under thermal conditions, they proceeded by 
disrotatory ring closure and the two substituents at position 1 and 6 had a stereochemical 
cis relationship (Scheme 3). 2,3           
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Scheme 3. Twofold Heck cross coupling and subsequent electrocyclization. Reagents and 
Conditions: (i) Pd(OAc)2, PPh3, NEt3 DMF, 90-100 °C; (ii) Pd/C (+O2) or S, 
xylene, 150 °C 
 
During the last couple of years, Prof. P. Langer’s research group has widely studied a 
number of 1,2-dihalogenated substrates for domino Heck / electrocyclization reactions and 
has extended the synthetic scope especially for the heteroaromatic 1,2-dihalides. This 
research group has reported that the corresponding benzo-annulated products can be 
synthesized by Heck cross-coupling of  2,3-dibromofuran 11,5 2,3-dibromothiophene 12,6 
2,3-dibromobenzofuran 13,7 2,3-dibromobenzothiophene 14,8 and 2,3-dibromo-N-
methylindole 15 with subsequent thermal 6π electrocyclization and oxidation in the 
presence of Pd/C (Scheme 4).2,3 
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Scheme 4. Reagents and Conditions: (i) Catalyst: Pd(OAc)2 (5 mol-%), XPhos or       
SPhos (10 mol-%), NEt3, DMF, 100-130 °C, 36 h; (ii) diphenyl ether or 
xylene, 200 °C, 24 h; (iii) Pd/C (10 mol-%), diphenyl ether, 130-200 °C,      
24-48 h  
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Cy = Cyclohexyl
MeOXPhos =
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iPriPr
iPr
SPhos =
 
Figure 1. Buchwald ligands35 
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 5 
The domino Heck cross-coupling / electrocyclization reaction of various alkenes with     
2,3-dibromonaphthoquinone (21) provided the anthraquinones 22 in a single step        
(Scheme 5).9  
O
O
Br
Br
R
21
O
O
X
X
i
22 (63-83 %)
R = CO2Alkyl, Ar  
 
Scheme 5. Reagents and Conditions: (i) Pd(OAc)2 (5 mol-%), SPhos (10 mol-%),        
NEt3 (8.0 equiv.), DMF, >110 °C, 8 h 
 
The domino Heck / electrocyclization reaction of p-tolylstyrene with 2,3-dibromoindenone 
(23) directly afforded the substituted fluorenone 24 in 60 % yield (Scheme 6).10  
 
4-MeC6H4
23
i
24 (60 %)
O
Br
Br
O
4-MeC6H4
4-MeC6H4
 
 
Scheme 6. Reagents and Conditions: (i) Pd(OAc)2 (5 mol-%), PCy3 (10 mol-%), NEt3, 
DMF, 40 °C, 36 h 
 
My work on twofold Heck / electrocyclization of 2,3-dibromobenzofuran successfully 
provided substituted dibenzofurans which are discussed in detail in chapter 2 of this 
dissertation. 
6 
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1.2   Regioselective Arylation by Suzuki-Miyaura Cross-Coupling Reaction 
 
In 1979 Akira Suzuki together with Miyaura reported the Suzuki-Miyaura reaction and he 
shared the Nobel Prize of 2010 with Negishi and Heck for palladium catalysis. The Suzuki 
reaction is a palladium catalyzed cross-coupling of an aryl or vinyl boronic acid with an aryl 
or vinyl halide or triflate. It is a powerful cross coupling method of arylation and also allows 
the synthesis of conjugated olefins and styrenes. The Suzuki coupling of a boronic acid 
with a halide or triflate has been developed into one of the most important cross-coupling 
reactions, contributing about a quarter of all current palladium-catalyzed cross-coupling 
reactions.11 
 
Pd(0)
Transmetallation
Oxidative additionReductive elimination
R2-B(OH)2  +  baseXB(OH)2
R1-Pd(II)-X
R1X
R1-Pd(II)-R2
R1-R2
 
Scheme 7. Catalytic cycle of the Suzuki reaction 
 
The rate of the Suzuki reaction mainly depends on the oxidative addition and 
transmetallation. The oxidative addition step is dependent on the reactivity of the substrate 
according to the order Ar-I > Ar-OTf > Ar-Br > Ar-Cl. The transmetallation is accelerated by 
the presence of base. In fact, the Suzuki-Miyaura cross-coupling reaction refers to the 
cross-coupling of organoboron compounds and carbon elecrophiles. 
7 
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For polyhalogenated substrates, the more electron deficient carbon atom will react first, 
but steric hinderance may also direct the regioselctivity. Hence, the  regioselectivity 
depends mainly on the electrophilicity of the halide or triflate. During the recent years, 
Prof. P. Langer’s research group has contributed considerable efforts for the regioselective 
arylation of aromatic halides and triflates. They have synthesized a large number of 
symmetrical and unsymmetrical arylated aromatic and heteroaromatic organic compounds 
bearing a broad spectrum of biological activitie and fluorescence activity. As this 
dissertation presents the continuation of Prof. P. Langer’s work in this area, so it will be 
meaningful to show briefly what has been recently done in this group.12  
 
P. Langer et. al. have reported the regioselective arylation of tetrabromothiophene 25 
where C-2 and C-5 are electronically favoured positions. Tetrabromothiophene with       
2.2 equivalents of arylboronic acids provided a regioselective approach to various 2,5-
diaryl-3,4-dibromothiophenes (26). Unsymmetrical tetraarylthiophenes were prepared by 
Suzuki reaction of 2,5-diaryl-3,4-dibromothiophenes with different types of aryl groups      
(Scheme 8). During the optimization of the reaction conditions, the solvent and the catalyst 
played an important role. In several cases, classical conditions [Pd(PPh3)4] gave excellent 
yields.13 
 
 
 
 
 
8 
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SBr Br
BrBr
Ar1B(OH)2
Ar1B(OH)2
SAr1 Ar1
BrBr
SAr1 Ar1
Ar1Ar1
SAr1 Ar1
Ar2Ar2
Ar2B(OH)2
25 27 (32-77 %)
i
26 (37-93 %)
ii
28 (51-93 %)
ii i
 
 
Scheme 8. Suzuki reactions of 25. Reagents and conditions: (i) 25 (1.0 equiv.),   
Ar1B(OH)2 (5.0 equiv.), Pd(PPh3)4 (10 mol-%), K3PO4 (8.0 equiv.), solvent;      
(ii) 25 (1.0 equiv.), Ar1B(OH)2 (2.2 equiv.), Pd(PPh3)4 (6 mol-%),            
K3PO4 (4.0 equiv.), solvent; (iii) 25 (1.0 equiv.), Ar2B(OH)2 (3.0 equiv.), 
Pd(PPh3)4 (10 mol-%), K3PO4 (4.0 equiv.), solvent 
 
Interestingly, recent work on Suzuki–Miyaura reactions of 2,3,5-tribromothiophene 29 
showed that the reaction with one, two, and three equivalents of arylboronic acids resulted 
in the formation of 5-aryl-2,3-dibromothiophenes 30, 2,5-diaryl-3-bromothiophenes 31, and 
2,3,5-triarylthiophenes 32, respectively. In this case, the first attack was observed at C-5 
which is sterically less hindered.14 
 
9 
 9 
SBr Br
Br
i
ii
iii
SBr Ar
Br
SAr Ar
Br
SAr Ar
Ar
29
30 (46-87 %)
31 (43-89 %)
32 (44-65 %)  
 
Scheme 9. Reagents and conditions: (i) 29 (1.0 equiv.), ArB(OH)2 (1.1 equiv.),      
Pd(PPh3)4 (5 mol-%), K2CO3 (2 M), 1,4-dioxane–toluene (1:1), 100 °C, 8 h; 
(ii) 29 (1.0 equiv.), ArB(OH)2 (2.2 equiv.), Pd(PPh3)4 (5 mol-%),              
K3PO4 (4.0 equiv.), 1,4-dioxane–toluene (1:1), 100 °C, 12 h;                  
(iii) 29 (1.0 equiv.), ArB(OH)2 (4.0 equiv.), Pd(PPh3)4 (10 mol-%),           
K2CO3 (2 M), 1,4-dioxane, 90 °C, 8 h 
 
The site-selectivity for tetrabromoselenophene,15 tetrabromofuran16 and N-methyl-
tetrabromopyrrole17 worked in the same way as for tetrabromothiophene 25. The 
optimization of the reaction conditions needed lot of efforts to prepare 33-35  (Figure 2).  
 
N
Me
Ar2
Ar1
Ar2
Ar1 Se
Ar2
Ar1
Ar2
Ar1 O
Ar2
Ar1
Ar2
Ar1
33 34 35  
 
Figure 2. Site-selectivity in Suzuki products 
10 
10 
 
The first Suzuki–Miyaura reactions of N-protected tribromopyrazoles 36 provided a series 
of arylated pyrazoles. Their reaction with three, two, or one equivalents of arylboronic 
acids afforded triarylpyrazoles 39, 3,5-diaryl-4-bromopyrazoles 38, or 5-aryl-3,4-
dibromopyrazoles 37, respectively (Scheme 10). The products are not readily available by 
other methods. All reactions proceeded with very good site-selectivity.17 
 
N N
R
Ar
Ar
Ar
ArB(OH)2
iii
N N
R
Br Br
Br
N N
R
Br Br
Ar
N N
R
Ar Br
Ar
i ii
36
37 (66-73 %)
38 (40-74 %)
39 (50-76 %)
R = Benzyl, Vinyl  
 
Scheme 10. Reagents and conditions: (i) 36 (1.0 equiv.), ArB(OH)2 (1.0 equiv.),          
K3PO4 (1.5 equiv.), Pd(PPh3)4 (3 mol-%), 1,4-dioxane / H2O (4:1), 100 C,    
12 h; (ii) 36 (1.0 equiv.), ArB(OH)2 (2.0 equiv.), K3PO4 (3.0 equiv.),     
Pd(PPh3)4 (5 mol-%), 1,4-dioxane / H2O (4:1), 100 C, 12 h;                          
(iii) 36 (1.0 equiv.), ArB(OH)2 (3.5 equiv.), K3PO4 (4.5 equiv.),             
Pd(PPh3)4 (10 mol-%), 1,4-dioxane / H2O (4:1), 100 C, 12 h 
 
Pyrimidines are of considerable pharmacological importance and occur in many synthetic 
drugs and natural products. Convenient regioeselective syntheses of mono-, di-, tri- and 
tetraaryl-pyrimidines (41-44) by Suzuki-Miyaura reactions of 2,4,5,6-tetrachloropyrimidine 
40 have been reported. The products reported are not readily available by other methods. 
All reactions proceeded with excellent site-selectivity under the influence of electronic 
effects showing the reactivity preference order C-4 > C-6 > C-2 > C-5.18  
11 
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N N
ClCl
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N N
Ar1Ar1
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Ar1B(OH)2
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N N
Ar1Ar1
Ar2
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ii
Ar2B(OH)2
ii i
Ar2B(OH)2
N N
Ar1Ar1
Ar2
Ar2
N N
ArCl
Cl
Cl
iv
ArB(OH)2
41 (93-97 %) 42 (85-97 %)
43 (86-90 %)
44 (79 %)  
 
Scheme 11. Reagents and Conditions: (i) 40 (1.0 equiv.), Pd(PPh3)2Cl2 (3 mol-%),   
K2CO3 (H2O, 2 M), dioxane, 60 °C, 2 h; (ii) Ar1B(OH)2 (2.0 equiv.),          
Pd(PPh3)2Cl2 (3 mol-%), K2CO3 (H2O, 2 M), dioxane, 70 °C, 5 h;                 
(iii) Ar2B(OH)2  (1.0 equiv.), Pd(PPh3)2Cl2 (3 mol-%), K2CO3 (H2O, 2 M), 
dioxane, 80 °C, 5 h; (iv) Ar2B(OH)2  (2.0 equiv.), Pd(PPh3)2Cl2 (3 mol-%), 
K2CO3 (H2O, 2 M), dioxane, 100 °C, 5 h 
 
The synthesis of 2,3-diarylindoles has also been accomplished by Suzuki–Miyaura 
reactions of N-methyl-2,3-dibromoindole 45. The nitrogen protective groups played an 
important role for the site-selectivity. The reaction with one equivalent of arylboronic acid 
resulted in site-selective formation of 2-aryl-3-bromoindoles 46. To synthesize 
unsymmetrical diarylindoles 47, because of the instability of 46, a one-pot strategy was 
developed. The one-pot reaction of 2,3-dibromoindole 45 with two different arylboronic 
acids afforded the unsymmetrical 2,3-diarylindoles 47 containing two different aryl groups 
(Scheme 12).19  
12 
12 
N
Me
Br
Br
N
Me
Br
Ar11) Ar
1B(OH)2 2) Ar2B(OH)2
45 46 47 (59-71 %)
N
Me
Ar2
Ar1
i ii
 
 
Scheme 12. One-pot synthesis of unsymmetrical 2,3-diarylindoles. Reagents and 
Conditions: (i) 45 (1.0 equiv.), Ar1B(OH)2  (1.1 equiv.), K3PO4 (1.5 equiv.), 
Pd(PPh3)4 (4 mol-%), 1,4- dioxane, 70 °C, 6 h; (ii) Ar2B(OH)2  (1.2 equiv.), 
K3PO4 (1.5 equiv.), 110 °C, 8 h 
 
Triflates of many aromatic and heteroaromatic organic compounds have been studied as 
well  for regioselective Suzuki reactions. For example, 7,8-diarylflavones 50 were prepared 
by Suzuki–Miyaura reactions of the bis(triflate) of 7,8-dihydroxyflavone. The first attack 
proceeded with very good site selectivity at position 7, due to steric and electronic 
reasons.20 
 
i
O Ph
O
OTf
TfO
Ar1B(OH)2
O Ph
O
Ar2
Ar1O Ph
O
OTf
Ar1
ii
Ar2B(OH)2
48 49 (66-76 %) 50 (66-73 %)  
 
Scheme 13. Reagents and conditions: (i) 48 (1.0 equiv.), Ar1B(OH)2 (1.0 equiv.),        
K3PO4 (1.5 equiv.), Pd(PPh3)4 (5 mol-%), 1,4-dioxane, 70 C, 4 h;             
(ii) 49 (1.0 equiv.), Ar2B(OH)2 (1.3 equiv.), K3PO4 (1.5 equiv.),          
Pd(PPh3)4 (5 mol-%), 1,4-Dioxane, 100 C, 4h 
 
In my thesis, I have investigated the site-selective Suzuki-Miyaura cross-coupling 
reactions of 2,3-dibromobenzofuran and 2,3,5-tribromobenzofuran which are discussed in 
chapter 3 of this dissertation. My results related to 2,3-dibromoindenone are described in 
detail in chapter 4. 
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2   Efficient Synthesis of Functionalized Dibezofurans by Domino     
Twofold Heck / 6-Electrocyclization Reactions of               
2,3-Dibromobenzofuran 
 
2.1   Introduction 
 
Benzofurans are of significant pharmacological importance and are found in many natural 
and non-natural products.21 Substituted furans are among the most significant classes of 
five-membered heterocycles and contribute a great deal of importance to pharmaceuticals 
and drugs and are widely found in natural and non-natural products. For example, 
synthetic amiodarone corresponds to a powerful antiarrythmic and antianginal remedy.22  
7-Alkanoylbenzofurans and 7-alkanoyl-2,3-dihydrobenzofurans are found in many natural 
products, for example longicaudatin,23 the sessiliflorols A and B, flemistrictin E, 
tovophenone C, vismiaguianone C or piperaduncin B.24 Dibenzofurans also occur in a 
variety of pharmacologically active natural products. Examples include simple 
hydroxylated derivatives (such as - and -cotonefuran and -pyrufuran (Figure 3),25    
aryl-substituted hydroxylated derivatives (e. g., candidusin A, vialinin B),26 brominated 
derivatives (e. g., corallinafuran),27 polycyclic derivatives (such as phlorofucofuroeckol A or 
mallotusinin),28 and complex glycosylated derivatives (e. g., fulicineroside).29 Furthermore, 
polysubstituted furans and benzofurans are significant precursors for the synthesis of 
natural and non-natural products. Hence, the assembly of polysubstituted benzofurans is 
an interesting part of organic synthesis.  
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MeO OMe
HO
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MeO
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Me Me
 
γ-Pyrufuran                                    Norascomatic acid 
 
Figure 3. Structures of some naturally occurring dibenzofurans 
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2.2   Results and discussion 
 
In recent years, it has been revealed that polyhalogenated heterocycles can be 
regioselectively functionalized in palladium(0)-catalyzed cross-coupling reactions by 
selective activation of a single halogen atom. The regioselectivity is controlled by 
electronic and steric factors.12 Sonogashira,30 Negishi,31 and Stille 32 coupling reactions of 
2,3- and 2,6-dibromobenzofuran have been reported to regioselectively occur at position 
C-2 and the same results I observed in case of Suzuki-Miyaura cross-coupling reactions of 
2,3-dibromobenzofuran. Bach and Bartels reported regioselective Negishi and Kumada 
cross-coupling reactions of 2,3,5-tribromobenzofuran.33 Herein, I will discuss the first Heck 
reactions of 2,3-dibromo- and 2,3,5-tribromobenzofuran which have, to the best of my 
knowledge, never been reported before. In this context, functionalized dibenzofurans were 
efficiently prepared based on domino twofold Heck / 6-electrocyclization reactions.34   
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Br
Br
O
Br
Br
Br
i
i i 13 (84 %)
52 (76 %)
51
 
 
Scheme 14. Bromination of benzofuran (51). Reagents and Conditions: (i) Br2 (2.0 equiv.),               
KOAc (2.0 equiv.) CH2Cl2, reflux, 4 h; (ii) Br2 (4.5 equiv.), KOAc (4.5 equiv.), 
CH2Cl2, reflux, 18 h 
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Bach and Bartels reported that the direct bromination of benzofuran (51), following the 
conditions reported by Antognazza et al.,34 resulted in the formation of a mixture of 
products. Therefore, a stepwise protocol was suggested for the synthesis of                  
2,3-dibromobenzofuran (13).30b I found that the reaction of 51 with bromine (2.0 equiv.) 
and KOAc (2.0 equiv.) in CH2Cl2 (reflux, 4 h) results in regioselective formation of          
2,3-dibromobenzofuran (13) in 84 % yield (Scheme 1). Bach and Bartels reported a 
stepwise synthesis of 2,3,5-tribromobenzofuran (52) which was prepared from                  
5-bromobenzofuran in 52 % yield.30b I have found that 52 is available in 76 % yield by 
reaction of 51 with bromine (4.5 equiv.) and KOAc (4.5 equiv.) in CH2Cl2 (reflux, 18 h).  
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Scheme 15. Synthesis of 54d,f,h,j and 18a-c,e,g,i. Reagents and Conditions:                  
(i) Pd(OAc)2 (5 mol-%), L (10 mol-%), NEt3 (8.0 equiv.), DMF, 70 °C, 12 h; 
(ii) Pd(OAc)2 (5 mol-%), L (structure see Figure 4, 10 mol-%), NEt3, DMF, 
100 °C, 48 h; (iii) Pd/C (10 mol-%), xylene, reflux, 48 h 
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The Heck reaction of 13 with acrylates and styrenes 53d,f,h,j (2.5 equiv.) afforded the  
2,3-di(alkenyl)benzofurans 54d,f,h,j in good yields (Scheme 15, Table 1). The reactions 
were carried successfully by using Pd(OAc)2 (5 mol-%) and the biaryl monophosphine 
ligand L (10 mol-%) which was recently developed by Buchwald and coworkers       
(Figure 4).35 The reactions were performed in DMF at 70 °C for 12 h. The employment of 
Pd(PPh3)4 was less successful in terms of yield. The Pd(OAc)2/L-catalyzed reaction of 13 
with alkenes 53a-c,e,g, carried out at 100 °C rather than 70 °C, afforded the                  
1,2-dihydrodibenzofurans 55a-c,e,g  as a mixture of two isomers. Their formation can be 
explained by a domino twofold Heck / thermal 6-electrocyclization and subsequent 
double bond migration (isomerization). Heating of a xylene solution of crude 55a-c,e,g in 
the presence of Pd/C resulted in the formation of dibenzofurans 18a-c,e,g in 46-84 % 
overall yields (based on 13). It is worth to be noted that, in contrast to Sonogashira and 
Stille reactions, the Heck monoalkenylated product could not be isolated. The reaction of 
13 with only one equivalent of acrylate 53f mainly resulted in the formation of 54f and 
some of the starting material was also recovered. This might be explained by the fact that 
carbon C-3 becomes more electron-deficient and, thus, more reactive, due to the electron-
withdrawing character of the 2-(tert-butoxycarbonyl)alkenyl substituent. Alternatively, a 
neighbourhood effect (chelation of the Pd(0) species by the alkenyl substituent attached to 
C-2) can be discussed. 
 
PCy2
OMe Cy = CyclohexylMeO
L =
 
 
Figure 4. Biaryl monophosphine ligand developed by Buchwald and coworkers.35 
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The Heck reaction of 13 with styrene 53i directly afforded the dibenzofuran 18i in            
83 % yield (Scheme 16). The dehydrogenation spontaneously occurred under the reaction 
conditions and did not require the use of Pd/C. Other styrenes could be also successfully 
employed.  
 
Table 1. Synthesis of 54d,f,h,j and 18a-c,e,g,i 
54,18 R % (54) a % (18) a 
a Et - b 73 
b nBu - b 76 
c iBu - b 84 
d              nHex 79 - b 
e 2-Ethylhexyl - b 74 
f tBu 72 - b 
g C6H5 - b 46 
h 4-MeC6H4 65 - b 
i 4- tBuC6H4 - b 68 
j 2-(OMe)C6H4 54 - b  
a Yields of isolated products based on 13  
b experiment was not carried out 
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Scheme 16. Synthesis of 18i. Reagents and Conditions: (i) Pd(OAc)2 (5 mol-%),               
L (10 mol-%), NEt3, DMF, 100 ˚C, 48 h 
 
The Heck reaction of 2,3,5-tribromobenzofuran (52) with acrylates 53c,f mainly resulted in 
the formation of the hydrogenated products 56a and 56b which were isolated as single 
isomers (Scheme 17). However, the exact structure could not be unambiguously assigned. 
Bach and Bartels reported that the Kumada coupling of 2-aryl-3,5-dibromobenzofuran,11 
derived from 52, occurs at carbon atom C-5 (Figure 5).17 I found that the Heck reaction of 
52 with 2 equiv of acrylate 53f resulted in functionalization of carbon atoms C-2 and C-3 
and in reduction of C-5 to give 54f. This result can be explained by the following 
assumption which has not yet been experimentally proven: the first reaction of 53f with 
52b occurs at position C-2 to give intermediate A (Figure 5). The reactivity of carbon C-3 
is increased by the neighbourhood effect of the (tert-butoxycarbonyl)-alkenyl substituent 
located at carbon C-2 (see above). Therefore, the second attack occurs at carbon C-3 
rather than at C-5. 
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Scheme 17. Synthesis of 56a,b. Reagents and Conditions: (i) Pd(OAc)2 (5 mol-%),           
L (10 mol-%), NEt3, DMF, 120 °C, 48 h 
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Figure 5. Regioselective reactions of 52 
 
2.3   Conclusion 
 
In conclusion, 2,3-dialkenylbenzofurans were prepared based on domino twofold        
Heck / 6-electrocyclization reactions of  2,3-dibromobenzofuran. The first attack of Pd(0) 
occurs at carbon C-2 which results in a significant increase of the reactivity of C-3. 
Therefore, the mono-Heck reaction product of 2,3-dibromobenzofuran could not be 
isolated. In case of 2,3,5-tribromobenzofuran, carbon atoms C-2 and C-3 are more 
reactive than C-5. 
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3   Site-Selective Suzuki Cross-Coupling Reactions of               
 2,3-Dibromobenzofuran and 2,3,5-Tribromobenzofuran 
 
3.1   Introduction 
 
Furans are key structural units as five-membered oxygen heterocycles in organic 
compounds. Especially, contributions of furans as versatile substrates for synthetic 
transformations are immense. As it has been described in chapter 2 of this dissertation, 
benzofurans are pharmacologically important heterocycles.36 For example, synthetic 
amiodarone represents a potent antiarrythmic and antianginal drug.37                          
7-Alkanoylbenzofurans and 7-alkanoyl-2,3-dihydrobenzofurans occur in a variety of natural 
products, such as longicaudatin,38 flemistrictin E, tovophenone C, vismiaguianone C, 
piperaduncin B, or the sessiliflorols A and B.39  
 
3.2   Results and discussion 
 
2,3-Dibromobenzofuran and 2,6-dibromobenzofuran represent interesting starting 
materials which have been used in site-selective Sonogashira, Negishi,30 and Stille31 
coupling reactions. Site-selective Negishi and Kumada cross-coupling reactions of     
2,3,5-tribromobenzofuran have also been reported.32 The Heck reactions of 2,3-
dibromobenzofuran have been described in chapter 2 of this dissertation.40  Herein, I 
present what are, to the best of my knowledge, the first Suzuki-Miyaura reactions of 2,3-
dibromobenzofuran and 2,3,5-tribromobenzofuran. These reactions proceed with excellent 
site-selectivity. I also have developed a one-pot protocol for the synthesis of 
unsymmetrical 2,3-diarylbenzofurans. 
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The Suzuki-Miyaura reaction of 2,3-dibromobenzofuran (13) with various arylboronic acids 
57a-k (2.0 equiv.) afforded the 2,3-diarylbenzofurans 58a-k (Scheme 18, Table 2).       
High yields were obtained for products derived from both electron-rich and electron-poor 
boronic acids. As by-products were observed the reduced products 60, due to the loss of 
bromine at C-3. Henc, the reduction at C-3 provides the major reason of lower yields 
during the Suzuki cross-coupling reactions of 13. This phenomenon was observed more 
explicitely during the synthesis of 3-bromo-2-arylbenzofurans 59 (Scheme 19, Table 3). 
Yet, I could isolate the reduced products 60i and 60j along with 58a and 58c in small 
yields, respectively. 
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ArB(OH)2
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Scheme 18. Synthesis of 58a-k. Reagents and Conditions: (i) 57a-k (2.0 equiv.), 
Pd(PPh3)4 (5 mol-%), aq. K2CO3 (2 M), dioxane, 80 °C, 8 h 
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Table 2. Synthesis of 2,3-diarylbenzofurans 58a-k 
57,58 Ar % (58) a 
a C6H5 93b 
b 4-MeC6H4 92 
c 2-MeC6H4 81c 
d 4-EtC6H4 86 
e 4-tBuC6H4 88 
f 2-ClC6H4 87 
g 4-ClC6H4 83 
h 4-FC6H4 81 
i 2-(MeO)C6H4 82 
j 2,5-(MeO)2C6H3 85 
k 3,5-Me2C6H3 79 
 
a Yields of isolated products,  
b reduced product 60i was isolated as by-product (04 %),  
c reduced product 60j was isolated as by-product (09 %) 
 
The structures of 59a-k were elucidated by NMR spectroscopy, but 58e, 58g and 58h 
were also confirmed by X-ray crystallography (Figures 6-8). 
23 
 23 
 
 
Figure 6. Crystal structure of 58e (SPGR P21, wR2 ca. 13 %) 
 
 
 
 
 
Figure 7. Regioselective reactions of 58g  (SPGR P-1, wR2 ca. 12 %) 
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Figure 8. Regioselective reactions of 58h  (SPGR P212121, wR2 ca. 10 %) 
 
The Suzuki-Miyaura reaction of 13 with 1.0 equiv. of arylboronic acids 57b,d,g,i,k-n 
afforded the 2-aryl-3-bromobenzofurans 59a-h in good yields (Scheme 19, Table 3). The 
reactions proceeded with very good site-selectivity. Hydrogenated by-products 60a,f-h 
were also isolated. Reduction at C-3 during the synthesis of 59g and 59h was the major 
reason for the lower yields (67 % and 63 %, respectively). 
 
In all reactions, Pd(PPh3)4 (5 mol-%) was used as the catalyst. The use of Pd(OAc)2 in the 
presence of XPhos35 or SPhos35 proved to be less successful in terms of yield. All 
reactions were carried out at 70-80 °C. For the mono-coupling it proved to be important to 
carry out the reaction at 70 °C because higher temperature provides a complex mixture of 
products. An aqueous solution of K2CO3 (2 M) was used as the base. The employment of 
K3PO4 gave equally good results. 1,4-Dioxane was used throughout as the organic 
solvent. 
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Scheme 19. Synthesis of 59a-e. Reagents and Conditions: (i) 57c,e,g-i (1.0 equiv.), 
Pd(PPh3)4 (5 mol-%), aq. K2CO3 (2 M), dioxane, 70 °C, 6 h 
 
Table 3. Synthesis of 2-aryl-3-bromobenzofuran 59a-e 
57 59, 60 Ar % (59) a % (60) a 
b a 4-MeC6H4 93 04 
d b 4-EtC6H4 86 -b 
g c 4-ClC6H4 90 -b 
i d 2-(MeO)C6H4 87 -b 
k e 3,5-Me2C6H3 79 -b 
l f 2,6-(MeO)2C6H3 89 5 
m g 3-( C6H5)2C6H4 67 23 
n h 2-Thienyl 63 15 
a Yields of isolated products 
 
The sequential addition of two different arylboronic acids allowed the direct synthesis of 
2,3-diarylbenzofurans 61a,b containing two different aryl groups (Scheme 20, Table 4). 
The yields of the products were significantly higher when the reactions were carried out 
following one-pot procedure without isolation of the mono-coupling product.  
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Scheme 20. Synthesis of 61a,b. Reagents and Conditions: (i) 1) 57b (1.0 equiv.), 
Pd(PPh3)4 (5 mol-%), aq. K2CO3 (2 M), dioxane, 70 °C, 6 h;                  
2) 57h,o (1.0 equiv.), 80 °C, 6 h 
 
Table 4. Synthesis of unsymmetrical 2,3-diarybenzofuran 61a,b 
61 Ar1 Ar2 % (61) a 
a 4-MeC6H4 3-(MeO)C6H4 76 
b 4-MeC6H4 4-FC6H4 79 
a Yields of isolated products 
 
The structures of all products 58, 59, 60 and 61 were established by spectroscopic 
methods. The structure of 61b was independently confirmed by X-ray crystal structure 
analysis as well (Figure 9). 
 
Figure 9. Crystal structure of 61b (SPGR Pbca, wR2 ca. 15 %) 
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The site-selectivity of the Suzuki-Miyaura reaction can be explained by the assumption 
that the oxidative addition of (nucleophilic) Pd(0) occurs more rapidly at the more electron-
deficient carbon atom (i.e., C-2) (Figure 10). 
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Figure 10. Possible explanation for the site-selectivity of the Suzuki-Miyaura reactions of 
13 
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Figure 11. NOESY and HMBC Correlations of Compound 59a  
 
The regioselectivity of compound 59a was unambiguously established with the help of 2D 
NMR as well. The relatively low chemical shift value of C-3 (δC 93.1) indicated that C-3 is 
not attached with any unsaturated moiety or aromatic ring. Tolyl protons H-2’/6’ resonating 
at δH 8.10 showed obvious HMBC correlations with carbon C-2 resonating at δC 151.8.                        
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No HMBC correlation of protons H-2’/6’ with C-3 was observed. Furthermore, the tolyl 
aromatic protons did not show a NOESY correlation with benzofuran proton H-4. This 
HMBC and NOESY correlation pattern including the small chemical shift value for carbon 
C-3 confirms that the tolyl moiety is attached to carbon C-2 of the benzofuran. 
 
Suzuki reactions of 2,3,5-tribromobenzofuran were also investigated. Its reaction with    
3.0 equivalents of 4-fluorophenylboronic acid using 5 mol-% of Pd(PPh3)4 provided 
triarylbenzofuran 62 in very good yield (81 %) (Scheme 21). 
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Scheme 21. Synthesis of 62. Reagents and Conditions: (i) 57h (3.0 equiv.),        
Pd(PPh3)4 (5 mol-%), aq. K2CO3 (2 M), dioxane, 90 °C, 8 h 
 
When 2,3,5-tribromobenzofuran was reacted with one equivalent of 4-tolylboronic acid it 
provided 3,5-dibromo-2-arylbenzofuran 63 in good yield (79 %) (Scheme 22). 
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Scheme 22. Synthesis of 63. Reagents and Conditions: (i) 57b (1.0 equiv.),        
Pd(PPh3)4 (5 mol-%), aq. K2CO3 (2 M), dioxane, 70 °C, 4 h 
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Figure 12. NOESY and HMBC Correlations of Compound 63  
 
The structure of 63 was confirmed by a detailed study of 1D and 2D NMR. The small 
chemical shift value of C-3 (δC 92.0) is due to the positive mesomeric effect of the furan 
oxygen atom. The value suggests that C-3 is not attached with any unsaturated moiety. 
Regioselectivity of compound 63 was explicitly established with the help of 2D NMR. 
Assignment of chemical shifts for C/CH/CH3 could be achieved by the splitting pattern of 
1H NMR and 2D NMR correlations (NOESY (H-H), HMQC, HMBC (H-C)). Tolyl aromatic 
protons H-2’/6’ resonating at δH 7.96 (d, J = 8.6 Hz) showed clear HMBC correlations with 
C-2 resonating at δC 151.8. Furthermore, H-2’/6’ did not show HMBC correlation with C-3. 
No NOESY correlation was observed with H-4 resonating at δH 7.20. All these facts 
established that the tolyl moiety is connected with C-2. 
 
3.3   Conclusion 
 
In conclusion, 2,3-diarylbenzofurans were prepared by Suzuki-Miyaura reactions of 2,3-
dibromobenzofuran with two equivalents of boronic acids. The reaction with one equivalent 
of arylboronic acids resulted in site-selective formation of 2-aryl-3-bromobenzofurans. 2,3-
diarylbenzofurans containing two different aryl groups were prepared from 2,3-
dibromobenzofuran in a one-pot protocol by sequential addition of two different boronic 
acids. Hydrogenated products were also isolated which can explain the moderate yields. 
30 
30 
4   One-Pot Synthesis of 2,3-Diarylindenones by Site-Selective Suzuki-
Miyaura Reactions of 1,2-Dibromoindenone  
 
4.1   Introduction 
 
Type 2 diabetes mellitus, also recognized as non-insulin-dependent diabetes mellitus, 
accounts for more than 90 % of the diabetes cases. This condition is characterized by high 
levels of glucose resulting from progressive insulin resistance and, at later stages of the 
disease, mutilation of insulin secretion. Peroxisome proliferator-activated receptors 
(PPARs) are one of the attractive diabetes target proteins. The indenone derivatives had 
been discovered as a unique pattern for the activation of PPARγ. The indenones are a 
novel and interesting chemical class for the treatment of diabetes type 2. For example, 
compound A (Figure 13) 41  has been reported to have very good agonistic activity with an 
EC50 value of 50 nM and exhibited a new binding mode in the X-ray cocrystal structure. 
Furthermore, nitrated indenoisoquinolines have been revealed as potent topoisomerase I 
(Top1) inhibitors as well. Hence, arylated-indenones are of considerable pharmacological 
relevance and worth for further studies.41  
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Figure 13. Compound A 
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4.2   Results and discussions 
 
Classic syntheses of these molecules rely on intramolecular Friedel-Crafts acylation 
reactions,42 on the reaction of 3-(p-methoxybenzal)phthalide with phenylmagnesium 
bromide and subsequent rearrangement,43 and on the reaction of 2-phenyl-1H-inden-
1,3(2H)-dione with phenylmagnesium bromide and subsequent extrusion of water.44 2,3-
Diaryl-1H-inden-1-ones have also been prepared from dibenzoylmethane 45 and 
benzophenone derivatives.46 Recent transition metal-catalyzed syntheses of 2,3-diaryl-1H-
inden-1-ones include the reaction of 1-methoxy-4-(4'-methoxyphenylethynyl)-benzene with 
2-bromobenzaldehyde,47 and the reaction of diphenyl acetylene with 2-
bromobenzeneboronic acid.48 
 
In recent years, a number of site-selective palladium(0)-catalyzed cross-coupling reactions 
of polyhalogenated heterocycles have been developed. The site-selectivity of these 
reactions is generally influenced by electronic and steric parameters.12-20 
 
It occurred to me that 2,3-dibromo-1H-inden-1-one might be a suitable starting material for 
the synthesis of 2,3-diaryl-1H-inden-1-ones. The reactions of 2,3-dibromo-1H-inden-1-one 
with amines and C-nucleophiles, such as Grignard reagents, ethyl cyanoacetate and ethyl 
acetoacetate, are known for a long time.49 Surprisingly, transition metal-catalyzed cross-
coupling reactions of 2,3-dibromo-1H-inden-1-one have, to the best of my knowledge, not 
been studied to date. Herein, I describe my research work for the synthesis of 2,3-diaryl-
1H-inden-1-ones by site-selective S-M reactions of 2,3-dibromo-1H-inden-1-one. The 
products are not readily available by other methods.  
32 
32 
The S-M reaction of 2,3-dibromo-1H-inden-1-one (23) 50 with two equivalents of 
arylboronic acids 57a,b,h,i,o-q gave the 2,3-diaryl-1H-inden-1-ones 64a-g in excellent 
yields (Scheme 10, Table 5). The best yields were obtained using 2.2 equiv. of the 
arylboronic acid, Pd(PPh3)4 (5 mol-%) as the catalyst, and K2CO3 (2 M aqueous solution) 
as the base (1,4-dioxane, 70 °C, 6 h).51 The employment of Pd(PPh3)2Cl2 proved to be 
less efficient in terms of yield. The reactions could be successfully carried out with both 
electron-rich and electron-poor arylboronic acids. 
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Scheme 23. Synthesis of 64a-g. Reagents and Conditions: (i) 57a,b,h,i,o-q (2.2 equiv.), 
Pd(PPh3)4 (5 mol-%), 2M K2CO3, dioxane, 70 °C, 6 h 
 
Table 5. Synthesis of  64a-g 
57 64 Ar % (64)a 
a a C6H5 97 
b b 4-MeC6H4 99 
h c 4-FC6H4 95 
i d 2-(MeO)C6H4 93 
o e 3-(MeO)C6H4 98 
p f 4-(MeO)C6H4 98 
q g 3-FC6H4 96 
a Yield of isolated products 
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The structures of the products were established by NMR. The structure of 65a was 
independently confirmed by X-ray crystal structure analysis (Figures 14). 
 
 
Figure 14. Crystal structure of 64a (SPGR P21/n, wR2 ca. 11 %) 
 
The S-M reaction of 23 with arylboronic acids 57b,k,l,o-q (1.0 equiv.) afforded the 3-aryl-2-
bromo-1H-inden-1-ones 65a-f in excellent yields and with very good site-selectivity 
(Scheme 24, Table 6). The first attack occurred at position C-3 of 23. During the 
optimization it proved to be very important to use exactly 1.0 equiv. of the arylboronic acid 
and Pd(PPh3)4 (3 mol-%) as the catalyst. The employment of Pd(PPh3)2Cl2 resulted in a 
significant decrease of the yield and of the site-selectivity. The temperature played an 
important role. A good selectivity was achieved only when the reaction was carried out at 
45 °C because the second cross-coupling was slow at this temperature.  
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The formation of a mixture of starting material, mono- and di-substituted products was 
generally observed when the reaction was carried out at temperatures between 45 and 70 
°C. In case of highly reactive methoxy-substituted arylboronic acids (57l,o,p), the 
temperature had to be further decreased to 40 °C to achieve a good site-selectivity. The 
reactions were successful for both electron-rich and electron-poor arylboronic acids. 
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Scheme 24. Synthesis of 65a-f. Reagents and Conditions: (i) 57b,k,l,o-q (1.0 equiv.), 
Pd(PPh3)4 (3 mol-%), 2M K2CO3, dioxane, 45 °C, 4 h 
 
Table 6. Synthesis of 3-aryl-2-bromoinden-1-ones 65a-f 
57 65 Ar % (65)a 
b a 4-MeC6H4 98 
k b 3,5-Me2C6H3 88 
l c 2,6-(MeO)2C6H3 83 b 
o d 3-(MeO)C6H4 95 b 
p e 4-(MeO)C6H4 93b 
q f 3-FC6H4 83 
a Yields of isolated products; b reaction temperature: 40 °C 
 
The structures of the products 65a-f were established by NMR experiments (NOESY, 
HMBC). The structure of 65c was independently confirmed by X-ray crystallography 
(Figure 15). 
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Figure 15. Crystal structure of 65c (SPGR P-1, wR2 ca. 7 %) 
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Figure 16. HMQC, NOESY and HMBC Correlations of Compound 65e  
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The structure of compound 65e (Figure 16) was also confirmed by 1D NMR and 2D NMR 
(HMQC, NOESY and HMBC). The protons of the 4-(MeO)C6H4 moiety H-2’/6’ (δH 7.60) 
provided a clear HMBC correlation with the indenone carbon C-3 (δC 155.5), but no 
correlation appeared for C-2 (δC 115.6) indicating the connectivity of C-3 with carbon C-1’. 
A key NOESY correlation of  H-2’/6’ (δH 7.60) with proton H-4 (δH 7.11) further established 
the fact that the 4-(MeO)C6H4 moiety is connected with C-3. 
 
The one-pot reaction of 23 with two different arylboronic acids, which were sequentially 
added, afforded the unsymmetrical 2,3-diaryl-1H-inden-1-ones 66a-g containing two 
different terminal aryl groups (Scheme 25, Table 7). During the optimization, it proved to 
be important that the first step was carried out at 45 °C (or at 40 °C in case of 66i,l) to 
achieve a good site-selectivity in favour of position C-3 of the substrate. The second step 
had to be carried out at 70 °C to guarantee a complete reaction of position C-2. All 
reactions proceeded in excellent yields. 
 
O
Br
Br
1) Ar1B(OH)2
i
23
2) Ar2B(OH)2
O
Ar2
Ar1
66a-g
 
 
Scheme 25. Synthesis of 66a-g. Reagents and Conditions: (i) 1) Ar1B(OH)2: 57b,d,       
i,l,r (1.0 equiv.), Pd(PPh3)4 (3 mol-%), 2M K2CO3, dioxane, 45 °C, 4 h;       
2) Ar2B(OH)2: 57b,g,h,l,p,r (1.1 equiv.), Pd(PPh3)4 (3 mol-%), 70 °C, 6 h 
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Table 7. Synthesis of 66a-g 
57 66 Ar1 Ar2 % (66) a 
b,p a 4-MeC6H4 4-(MeO)C6H4 93 
b,r b 4-MeC6H4 3-ClC6H4 89 
l,h c 2,6-(MeO)2C6H3 b 4-FC6H4 86 
b,l d 4-MeC6H4 2,6-(MeO)2C6H3 90 
i,b e 2-(MeO)C6H4 b 4-MeC6H4 85 
d,g f 4-EtC6H4  4-ClC6H4 83 
r,b g 3-ClC6H4  4-MeC6H4 79 
 a Yields of isolated products; b reaction temperature: 40 °C 
 
 
Figure 17. Crystal structure of 66d (SPGR Pbcn, wR2 ca. 14 %) 
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The site-selective formation of 65a-f and 66a-g can be explained by electronic reasons. 
The first attack of palladium(0) catalyzed cross-coupling reactions generally occurs at the 
more electron deficient and sterically less hindered position. Position C-3 of 2,3-dibromo-
1H-inden-1-one (23) is considerably more electron-deficient than position C-2. Handy and 
Zhang reported a simple guide for the prediction of the site-selectivity of palladium(0) 
catalyzed cross-coupling reactions of polyhalogenated substrates based on the 1H NMR 
chemical shift values of the non-halogenated analogues. In fact, the 1H NMR signal of 
proton H-3 of inden-1-one is shifted downfield compared to proton H-2. 
              
Less electron deficient
More electron deficient
O
Br
Br
23  
Figure 18. Possible explanation for the site-selectivity of cross-coupling reactions of 23 
 
4.3   Conclusion 
 
In conclusion, I have performed site-selective Suzuki-Miyaura reactions of 2,3-dibromo-
1H-inden-1-one which provide a convenient and site-selective approach to achieve 
arylated indenones. The Suzuki-Miyaura reaction of 2,3-dibromo-1H-inden-1-one with two 
equivalents of arylboronic acid gave 2,3-diaryl-1H-inden-1-ones. The reaction with one 
equivalent of arylboronic acid gave 2-bromo-3-aryl-1H-inden-1-ones with very good site-
selectivity. The one-pot reaction of 2,3-dibromo-1H-inden-1-one with two different 
arylboronic acids afforded 2,3-diaryl-1H-inden-1-ones containing two different terminal aryl 
groups. 
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5   Abstract 
 
An overview of domino twofold Heck / 6-electrocyclization reactions and site-selective 
Suzuki-Miyaura reactions is given. 
 
2,3-Dibromobenzofuran and 2,3,5-tribromobenzofuran were prepared from benzofuran. 
Functionalized dibenzofurans were prepared based on domino twofold                  
Heck / 6-electrocyclization reactions of 2,3-di- and 2,3,5-tribromobenzofuran. 
The Suzuki–Miyaura reaction of 2,3-dibromobenzofuran with two equivalents of boronic 
acids gave 2,3-diarylbenzofurans. The reaction with one equivalent of arylboronic acids 
resulted in site-selective formation of 2-aryl-3-bromobenzofurans. 2,3-Diarylbenzofurans 
containing two different aryl groups were  prepared from 2,3-dibromobenzofuran in a   
one-pot protocol by sequential addition of two different boronic acids. 
 
The first transition metal-catalyzed cross-coupling reactions of 2,3-dibromo-1H-inden-1-
one are investigated. The Suzuki-Miyaura reaction of 2,3-dibromo-1H-inden-1-one with 
two equivalents of arylboronic acid gave 2,3-diaryl-1H-inden-1-ones. The reaction with one 
equivalent of arylboronic acid gave 2-bromo-3-aryl-1H-inden-1-ones with very good site-
selectivity. The one-pot reaction of 2,3-dibromo-1H-inden-1-one with two different 
arylboronic acids afforded 2,3-diaryl-1H-inden-1-ones containing two different terminal aryl 
groups. 
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Ein Überblick zu Domino Heck / 6-Electrocyclisierungs Reaktionen und regioselektiven 
Suzuki-Miyaura Reaktionen wird gegeben. 
 
2,3-Dibromobenzofuran und 2,3,5-Tribromobenzofuran wurden aus Benzofuran 
hergestellt. Funktionalisierte Dibenzofurane wurden durch Domino Heck / 6-
Electrocyclisierungs Reaktionen von 2,3-Di- and 2,3,5-Tribromobenzofuran hergestellt. 
Die Suzuki–Miyaura Reaktion von 2,3-Dibromobenzofuran mit zwei Äquivalenten 
Boronsäuren ergab 2,3-Diarylbenzofurane. Die Reaktion mit einem Äquivalent von 
Arylboronsäure resultierte in regioselektiver Bildung von 2-Aryl-3-bromobenzofuranen. 2,3-
Diarylbenzofurane mit zwei unterschiedlichen Arylgruppen wurden ausgehend von 2,3-
Dibrombenzofuran in einer One-Pot Reaktion durch sequenzielle Addition von zwei 
unterschiedlichen Boronsäuren hergestellt. 
 
Die ersten Übergangsmetall-katalysierten Kreuzkupplungsreaktionen von 2,3-Dibrom-1H-
inden-1-on wurden untersucht. Die Suzuki-Miyaura Reaktion von 2,3-Dibrom-1H-inden-1-
on mit zwei Äquivalenten von Arylboronsäuren ergab 2,3-Diaryl-1H-inden-1-one. Die 
Reaktion mit einem Äquivalent von Arylboronsäuren lieferte 2-Brom-3-aryl-1H-inden-1-one 
mit sehr guter Regioselektivität. Die One-Pot Reaktion von 2,3-Dibromo-1H-inden-1-on mit 
zwei unterschiedlichen Arylboronsäuren lieferte 2,3-Diaryl-1H-inden-1-one mit zwei 
verschiedenen terminalen Arylgruppen. 
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Experimental Section 
 
6   Material and Methods  
 
6.1   General Remarks  
 
Reactions were carried out under inert atmosphere (Argon 4.6) in order to simultaneously 
exclude oxygen and water when appropriate. Pressure tubes were used to avoid 
condenser. Solvents for reactions were dried and distilled by standard methods or 
purchased from Merck, Aldrich, Acros Organics, and others whenever exclusion of water 
was desired. Solvents for liquid chromatography and extraction were always distilled prior 
to use and partly reused after fractional distillation (n-heptane, ethyl acetate).  
 
6.2   Methods for Compound Characterization and Analysis  
 
NMR Spectroscopy  
 
Bruker AC 250, Bruker ARX 300, Bruker ARX 500. For NMR characterization the one-
dimensional 1H NMR, proton-decoupled 13C NMR, and DEPT 135 spectra were collected. 
If necessary, other techniques (NOESY, COSY, HMQC, HMBC) were applied as well. All 
NMR spectra presented in this work were collected in CDCl3 solution. All chemical shifts 
are given in ppm.  
References (1H NMR): TMS (δ = 0.00) or residual CHCl3 (δ = 7.26) were taken as internal 
standard.  
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References (13C NMR): TMS (δ = 0.0) or residual CHCl3 (δ = 77.0) were taken as internal 
standard.  
 
Multiplicities are given as follows: s = singlet, d = doublet, t = triplet, q = quartet,               
m = multiplet, br = broad signal. More complex coupling patterns are represented by 
combinations of the respective symbols. For example, td indicates a triplet of doublets with 
the larger coupling constant associated with the first symbol (here: triplet).  
 
Infrared Spectroscopy (IR)  
 
Nicolet 205 FT-IR, Nicolet Protége 460 FT-IR. Peaks are given the following assignments: 
w = weak, m = medium, s = strong, br = broad.  
 
Mass Spektrometry (MS)  
 
AMD MS40, Varian MAT CH 7, MAT 731 (EI, 70 eV), Intecta AMD 402 (EI, 70 eV and CI), 
Finnigan MAT 95 (CI, 200 eV).  
 
High Resolution Mass Spectrometry (HRMS)  
 
Varian MAT 311, Intecta AMD 402.  
 
Elemental Analysis  
 
LECO CHNS-932, Thermoquest Flash EA 1112.  
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Melting Points  
 
Micro heating table HMK 67/1825 Kuestner (Büchi Apparatus), Leitz Labolux 12 Pol with 
heating table Mettler FP 90. Melting points are uncorrected.  
 
Rotation Angles  
 
LμP (IBZ Meßtechnik, NaD = 589 nm).  
 
X-ray Structures 
 
Bruker X8Apex diffractometer with CCD camera (Mo K
α
 radiation and graphite 
monochromator, λ = 0.71073 Å). The space group is determined by the XPREP program 
and the structures were solved via the SHELX-97 program package. Refinements were 
carried out according to the minimum square error method.  
 
 6.3   Chromatographic Methods  
 
Thin Layer Chromatography (TLC)  
 
Merck Kieselgel 60 F254 on aluminium foil from Macherey-Nagel. Detection was carried 
out under UV light at 254 nm and 365 nm. As colourizing reagent the following mixtures 
were used: 1-2/100 p-Anisaldehyde or vanillin, 10/100 glacial acetic acid, 5/100 sulphuric 
acid, 83-84/100 methanol.  
 
Column Chromatography  
 
Column chromatography was performed with Merck Silica Gel 60 or Macherey-Nagel 
Silica Gel 60 (0.063-0.200 mm, 70-230 mesh). The finer Merck Silica Gel 60 (0.040-  
0.063 mm, 230-400 mesh) was chosen when appropriate.  
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7   General Procedures  
 
7.1   Efficient Synthesis of Functionalized Dibezofurans by Domino Twofold 
Heck / 6-Electrocyclization Reactions of 2,3-Di- and                
2,3,5 Tribromobenzofuran 
 
 
General procedure A for the synthesis of 54, 55 and 18. In a pressure tube a DMF 
suspension (5 mL) of Pd(OAc)2 (12 mg, 0.05 mmol, 2.5 mol-% per Br atom of the 
substrate) and of dicyclohexyl(2',6'-dimethoxybiphenyl-2-yl)phosphine (L) (41 mg,        
0.10 mmol) was purged with Argon and the mixture was stirred at 20 °C to give a yellowish 
to brownish clear solution. To the stirred solution were added 13 or 52 (1.0 mmol),       
NEt3 (1.1 mL, 8.0 mmol) and the acrylate 53 (1.25 equiv. per Br atom of the substrate). 
The reaction mixture was stirred at 70°C - 100 °C for 12 - 48 h. The solution was cooled to     
20 °C, poured into H2O and CH2Cl2  (25 mL each), and the organic and the aqueous layer 
were separated. The latter was extracted with CH2Cl2 (3 x 25 mL). The combined organic 
layers were washed with H2O (3 x 20 mL), dried (Na2SO4), and concentrated in vacuo. 
The residue was chromatographed (flash  silica gel, heptanes/EtOAc) to give 54, 55 and 
18. 
 
7.1.1   Synthesis of 54 
 
(2E,2'E)-Dihexyl 3,3'-(benzofuran-2,3-diyl)diacrylate (54d): 
Starting with 13 (276 mg, 1.0 mmol), following the general 
procedure A, 54d was prepared as a brownish highly viscous 
oil (337 mg, 79 %). 1H NMR (300 MHz, CDCl3):  = 0.82-0.86 
(m, 6H, 2CH3), 1.24-1.37 (m, 12H, 6CH2), 1.61-1.71 (m, 4H, 
2CH2), 4.17 (t, 2H,  J = 6.8 Hz, CH2O), 4.18 (t, 2H, J = 6.8 Hz, 
CH2O), 6.58 (d, 1H, J = 16.0 Hz, CH), 6.60 (d, 1H, J = 15.5 Hz, CH), 7.24-7.30 (m, 1H, 
O
O
O
O
O
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ArH), 7.36 (td, 1H,        J = 1.3, 8.3 Hz, ArH), 7.42-7.45 (m, 1H, ArH), 7.73 (d, 1H, J = 15.5 
Hz, CH), 7.77-7.81 (m, 1H, ArH), 7.85 (d, 1H, J = 16.1 Hz, CH). 13C NMR (62.9 
MHz,CDCl3):  = 14.0 (2CH3), 22.5, 25.5, 25.6, 28.6, 28.7, 31.4, 31.5 (CH2), 65.0, 65.2 
(CH2O), 111.8 (CH), 119.0 (C), 120.8, 121.4, 121.6, 124.1 (CH), 125.8 (C), 127.3, 127.5, 
132.8 (CH), 152.9, 155.2 (C), 166.3, 166.8 (CO). IR (KBr): v = 3070, 3043 (w), 2956, 2931, 
2857 (m), 1710, 1628 (s), 1583 (m), 1537 (w), 1469, 1448 (m), 1398, 1378, 1351 (w), 
1308 (s), 1292 (m), 1278, 1257 (s), 1201 (m), 1173 (s), 1103, 1062, 1021, 1011 (m), 967, 
959 (s), 876, 859, 847, 768 (m), 752 (s), 731, 716, 708, 673, 588 (m) cm-1. MS (EI, 70 eV): 
m/z (%) = 426 ([M]+, 5), 297 (29), 296 (20), 239 (15), 214 (15), 213 (100), 212 (30), 195 
(56), 169 (30), 168 (11), 139 (10), 43 (20). HRMS Pos (ESI): calcd for C26H35O5 [M+H]+: 
427.2479; found: 427.24766. 
 
(2E,2'E)-tert-Butyl 3,3'-(benzofuran-2,3-diyl)diacrylate (54f): Starting with 13 (276 mg, 
1.0 mmol), following the general procedure A, 54f was prepared 
as a brownish highly viscous oil (266 mg, 72 %).                  
1H NMR (250 MHz, CDCl3):  = 1.47 (s, 9H, 3CH3), 1.48 (s, 9H, 
3CH3), 6.47 (d, J = 16.1 Hz, 1H, CH), 6.52 (d, J = 15.5 Hz, 1H, CH), 7.18-7.40 (m, 3H, 
ArH), 7.59 (d, J = 15.9 Hz, 1H, CH), 7.71 (d, J = 16.1 Hz, 1H, CH), 7.72-7.75 (m, 1H, ArH). 
13C NMR (62.9 MHz, CDCl3):  = 28.1, 28.2 (3CH3), 80.9, 81.1 (C), 111.6 (CH), 118.7 (C), 
121.6, 122.6, 123.2, 124.0 (CH), 125.9 (C), 126.7, 127.0, 131.8 (CH), 152.8, 155.1 (C), 
165.5, 165.9 (CO). IR (KBr): v = 3400, 3061 (w), 2976, 2930, 1801 (m), 1704 (s), 1635, 
1476, 1450, 1392 (m), 1367 (s), 1304, 1282 (m), 1255, 1143, 969 (s), 949, 880, 844,     
809 (m), 746 (s), 670, 632, 611, 581, 539 (m) cm-1. 
O
O
O
O
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2,3-Bis(4-methylstyryl)benzofuran (54h): Starting with 13 (276 mg, 1.0 mmol), following 
the general procedure A, 54h was prepared as a brownish 
highly viscous oil (227 mg, 65 %). 1H NMR (300 MHz, CDCl3):   
 = 2.41 (s, 3H, CH3), 2.42 (s, 3H, CH3), 7.22-7.37 (m, 10H, 
ArH/olefinic CH), 7.50-7.53 (m, 5H, ArH), 7.927.95 (m, 1H, ArH). 
13C NMR (62.9 MHz,CDCl3):  =  21.3, 21.4 (CH3), 111.0,   
113.0 (CH), 116.0 (C), 117.6, 120.9, 123.0, 125.1, 126.2, 126.8 (CH), 127.4 (C), 129.5, 
129.6, 130.1, 130.6 (CH), 134.0, 135.0, 137.5, 138.4, 152.6, 154.6 (C). IR (KBr): v = 3021, 
2919, 2857 (m), 1896 (w), 1711 (s), 1605 (m), 1571, 1538 (w), 1510, 1475 (m), 1450 (s), 
1442, 1358, 1284, 1266, 1250 (m), 1218, 1193 (s), 1181, 1155, 1122, 1110, 1095, 1038, 
1018 (m), 951 (s), 887, 850 (m), 799 (s), 771 (m), 741 (s), 703, 594, 532 (m) cm-1.                  
MS (EI, 70 eV): m/z (%) = 350 ([M]+, 100), 349 (12), 335 (14), 259 (12), 245 (19).      
HRMS (EI, 70 eV): calcd for C26H22O [M]+: 350.16652; found: 350.16599. 
 
2,3-Bis(2-methoxystyryl)benzofuran (54j): Starting with 13 (276 mg, 1.0 mmol), 
following the general procedure A, 54j was prepared as a brownish 
highly viscous oil (206 mg, 54 %). 1H NMR (300 MHz, CDCl3):       
 = 3.86 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 6.68-6.98 (m, 4H, 
Ar/olefinic CH), 7.20-7.33 (m, 6H, ArH), 7.41-7.44 (m, 1H, ArH), 
7.53-7.66 (m, 4H, Ar/olefinic CH), 7.87-7.90 (m, 1H, ArH).          
13C NMR (62.9 MHz,CDCl3):  = 55.5, 55.6 (OCH3), 110.9, 111.0, 111.1, 114.7 (CH), 
116.6 (C), 119.0, 120.8, 121.1, 123.0, 124.9, 125.0, 125.5 (CH), 125.8 (C), 126.0, 127.0 
(CH), 127.5 (C), 128.6, 129.2 (CH), 153.0, 154.7, 156.8, 157.4 (C). IR (KBr): v = 3066, 
3030, 2999 (w), 2924, 2834, 1595, 1575 (m), 1557, 1538 (w), 1481, 1462 (m), 1450 (s), 
1434, 1393, 1349, 1330, 1289 (m), 1239 (s), 1207, 1177, 1160 (m), 1102 (s), 1049 (m), 
1024, 949 (s), 887, 849, 784 (m), 741 (s), 670, 645, 615, 574, 535 (m) cm-1.                  
MS (EI, 70 eV): m/z (%) = 23), 382 ([M]+, 100), 380 (10), 275 (14), 274 (15), 263 (21), 261 
(14), 259 (10), 231 (13), 161 (16), 135 (18), 121 (21), 97 (11), 91 (24), 83 (12), 77 (12), 71 
(14), 69 (14), 57 (21), 55 (16), 44 (53), 43 (25), 41 (14). HRMS Pos (ESI) calcd for 
C26H23O3 [M+H]+: 383.16417; found 383.16473. 
 
  
O O
O
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General procedure B for the synthesis of dibenzofurans 18 from 55. To the isomeric 
mixture 55 were added xylene (3 mL) and Pd/C (30 mg, 10 mol-%). The solution was 
stirred under reflux for 48 h under Argon atmosphere. The reaction mixture was filtered 
and the filtrate was concentrated in vacuo. The residue was purified by chromatography 
(flash silica gel, heptanes/EtOAc) to give 18. 
 
7.1.2 Synthesis of dibenzofurans 18 from 55. 
 
Diethyl dibenzo[b,d]furan-2,3-dicarboxylate (18a): Starting with 13 (276 mg, 1.0 mmol), 
following the general procedures A and B, 18a was prepared 
as a light yellow highly viscous oil (227 mg, 73 %).                
1H NMR (300 MHz, CDCl3):  = 1.34 (t, 3H, J = 7.2 Hz, CH3), 
1.35 (t, 3H, J = 7.1 Hz, CH3), 4.35 (q, 4H, J = 7.2 Hz, 2CH2O), 7.31-7.37 (m, 1H, 
ArH), 7.47 (td, 1H, J = 8.4, 1.5 Hz, ArH), 7.54-7.57 (m, 1H, ArH), 7.82 (s, 1H, ArH), 7.91-
7.95 (m, 1H, ArH), 8.29 (d, 1H, J = 0.2 Hz, ArH). 13C NMR (62.9 MHz, CDCl3):  = 14.1, 
14.2 (CH3), 61.7, 61.9 (CH2O), 112.1, 112.5, 121.4, 122.1 (CH), 123.0 (C), 123.6 (CH), 
126.3, 127.0 (C) 128.7 (CH), 131.8, 156.7, 157.5 (C), 167.5, 167.6 (CO).                  
IR (KBr): v = 3073, 2980, 2928, 2871, 2853 (w), 1717 (s), 1635, 1602, 1578 (w), 1454, 
1368, 1304 (m), 1275, 1245, 1220, 1192, 1179, 1100, 1061, 1016 (s), 960, 910, 901, 877, 
859, 840, 719, 767 (w), 747 (s), 722, 693, 663, 601, 565 (m) cm-1. GC-MS (EI, 70 eV):  
m/z (%) = 312 ([M]+, 37), 267 (15), 240 (18), 239 (100), 166 (8). HRMS (EI, 70 eV): calcd 
for C18H16O5 [M]+: 312.09923; found: 312.09906. 
O
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O
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Dibutyl dibenzo[b,d]furan-2,3-dicarboxylate (18b): Starting with 13 (276 mg, 1.0 mmol), 
following the general procedures A and B, 18b was 
prepared as a light yellow highly viscous oil (280 mg, 76 %). 
1H NMR (250 MHz, CDCl3):  = 0.91 (t, 3H, J = 7.2 Hz, CH3), 
0.92 (t, 3H, J = 7.5 Hz, CH3), 1.33-1.45 (m, 4H, 2CH2), 1.64-
1.76 (m, 4H, 2CH2), 4.30 (t, 4H, J = 6.7 Hz, 2CH2O), 7.31-7.38 (m, 1H, ArH), 7.47 (td, 1H, 
J = 8.3, 1.4 Hz, ArH), 7.54-7.58 (m, 1H, ArH), 7.82 (s, 1H, ArH), 7.92-7.96 (m, 1H, ArH), 
8.28 (s, 1H, ArH). 13C NMR (75.5 MHz, CDCl3):  = 12.8, 13.1 (CH3), 28.7, 29.6, 29.7,  
30.9 (CH2), 64.7, 64.8 (CH2O), 111.1, 111.5, 120.4, 121.1, 122.6 (CH), 125.3, 126.2,  
126.5 (C), 127.7 (CH), 130.8, 155.7, 156.5 (C), 166.6 (2CO). IR (KBr): v = 2957 (m),   
2922 (s), 2852 (m), 1724 (s), 1638, 1603, 1579 (w), 1454, 1379, 1349, 1305 (m), 1276, 
1249, 1220 (s), 1192, 1178 (m), 1101, 1065 (s), 1018, 966, 843, 783, 767 (m), 748 (s), 
722, 698 (m), 602, 564 (w) cm-1. MS (EI, 70 eV): m/z (%) = 368 ([M]+, 13), 256 (32), 240 
(14), 239 (100), 212 (10), 57 (14). HRMS (EI, 70 eV): calcd for C22H24O5 [M]+: 368.16183; 
found: 368.16208. 
 
Diisobutyl dibenzo[b,d]furan-2,3-dicarboxylate (18c): 
Starting with 13 (276 mg,         1.0 mmol), following the general 
procedures A and B, 18c was prepared as a brownish highly 
viscous oil (309 mg, 84 %).     1H NMR (250 MHz, CDCl3):  = 
0.94 (d, 6H, J = 6.8 Hz, 2CH3), 0.95 (d, 6H, J = 6.78 Hz, 2CH3), 1.93-2.10 (m, 2H, aliphatic 
CH), 4.10 (d, 4H, J = 6.8 Hz, 2CH2O), 7.30-7.37 (m, 1H, ArH), 7.43-7.56 (m, 2H, ArH), 
7.82 (s, 1H, ArH), 7.91-7.95 (m, 1H, ArH), 8.27 (s, 1H, ArH). 13C NMR (62.9 MHz, CDCl3): 
  = 19.2 (4CH3), 27.7, 27.8 (CH), 71.9, 72.0, (CH2O), 112.1, 112.5, 121.4, 122.0 (CH), 
123.6 (C), 124.1 (CH), 126.3, 127.3 (C), 128.7 (CH), 131.8, 156.6, 157.5 (C), 167.5, 167.6 
(CO). IR (KBr): v = 3072, 2959, 2873 (m), 1719 (s), 1636, 1602, 1577 (w), 1454, 1393, 
1376, 1350, 1306 (m), 1274, 1239, 1219, 1778, 1111, 1100, 1060 (s), 1011, 983 (m), 945, 
900, 848, 881, 767 (w),     746 (m), 722, 694, 602, 564 cm-1. MS (EI, 70 eV): m/z (%) = 
O
O
O
O
O
O
O
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368 ([M]+, 9), 256 (62), 240 (15), 239 (100),   213 (11), 212 (13), 195 (10). HRMS (EI, 70 
eV): calcd for C22H24O5 [M]+: 368.16183; found: 368.16179. 
 
Bis(2-ethylhexyl) dibenzo[b,d]furan-2,3-dicarboxylate (18e): Starting with 13 (276 mg, 
1.0 mmol), following the general procedures A and B, 18e was 
prepared asa brownish highly viscous oil (355 mg, 74 %).       
1H NMR (300 MHz, CDCl3):  = 0.82- 0.90 (m, 12H, 4CH3), 
1.25-1.36 (m, 16H, 8CH2), 1.58-1.70 (m, 2H, aliphatic CH), 
4.19 (d, 2H, J = 6.0 Hz, CH2O), 4.20 (d, 2H, J = 5.8 Hz, CH2O), 
7.30-7.36 (m, 1H, ArH), 7.46 (td, 1H, J = 1.4, 8.2 Hz, ArH), 
7.53-7.56 (m, 1H, ArH), 7.80 (d, 1H, J = 0.2 Hz, ArH), 7.91-7.93 (m, 1H, ArH), 8.24 (d, 1H, 
J = 0.2 Hz, ArH). 13C NMR (62.9 MHz, CDCl3):  = 11.0, 14.0  (2CH3), 23.0, 23.8, 29.0 
(4CH2), 38.8 (CH), 68.3, 68.4 (CH2O), 112.1, 112.5, 121.3, 122.0 (CH), 123.0 (C), 123.6 
(CH), 126.3, 127.4 (C), 128.7 (CH), 131.8, 156.6, 157.5 (C), 167.5, 167.7 (CO). IR (KBr):  
v = 2957, 2928, 2872, 2859 (m), 1721 (s), 1637, 1602, 1574 (w), 1454, 1379, 1349,    
1305 (m), 1275, 1237, 1219 (s), 1190, 1179 (m), 1101 (s), 1062, 1011, 907, 781, 767 (m), 
746, 731 (s), 695, 648 (m), 602, 564 (w) cm-1. MS (EI, 70 eV): m/z (%) = 480 ([M]+, 1),  
257 (25), 256 (69), 240 (17), 239 (100), 57 (9). HRMS (EI, 70 eV): calcd for C30H40O5 [M]+: 
480.28703; found: 480.28739. 
 
2,3-Diphenyldibenzo[b,d]furan (18g): Starting with 13 (276 mg, 1.0 mmol), following the 
general procedures A and B, 18g was prepared as a brownish 
highly viscous oil (147 mg, 46 %). 1H NMR (300 MHz, CDCl3):       
 = 7.17-7.36 (m, 10H, ArH), 7.41- 7.44 (m, 1H, ArH), 7.51-7.54 
(m, 4H, ArH), 7.84-7.86 (m, 1H, ArH). 13C NMR (62.9 MHz,CDCl3):  = 111.1, 113.9 (CH), 
116.3 (C), 118.5, 121.0, 123.1, 126.3, 126.9 (CH), 127.3 (C), 128.3, 128.7, 128.8, 130.3, 
130.8 (CH), 136.7, 137.7, 152.6, 154.7 (C). IR (KBr): v = 3079, 3051, 3024, 2924, 2852 
(m), 1941, 1888 (w), 1795, 1738, 1660, 1629, 1595, 1577, 1537, 1492, 1475 (m), 1446 (s), 
O
O
O
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1348, 1316, 1279, 1265, 1248, 1209 (m), 1192 (s), 1155, 1123, 1096, 1072, 1017 (m),  
948 (s), 908, 885, 846 (m), 736, 688, 647 (s), 620, 574 (m) cm-1. GC-MS (EI, 70 eV):     
m/z (%) = 320 ([M]+, 100), 289 (9). HRMS (EI, 70 eV): calcd for C24H16O [M]+: 320.11957; 
found: 320.11959. 
 
2,3-Bis(4-tert-butylphenyl)dibenzo[b,d]furan (18i): Starting with 13 (276 mg,              
1.0 mmol), following the general procedures A and B, 18i was 
prepared asa brownish highly viscous oil (294 mg, 68 %).    
1H NMR (250 MHz, CDCl3):  = 1.21 (s, 9H, 3CH3), 1.22 (s, 
9H, 3CH3), 7.03 (d, 4H, J = 8.2 Hz, ArH), 7.14 (d, 2H, J = 8.4 
Hz, ArH), 7.16 (d, 2H, J = 8.6 Hz, ArH), 7.22-2.30 (m, 1H, ArH), 7.36 (td, 1H, J = 1.5, 8,4 
Hz, ArH), 7.47-7.51 (m, 1H, ArH), 7.53 (s, 1H, ArH), 7.7.83-7.86 (m, 1H, ArH), 7.88 (s, 1H, 
ArH). 13C NMR (75.5 MHz,CDCl3):  = 31.3, 31.4 (3CH3), 34.4, 34.5 (C), 111.7, 113.1, 
120.7, 122.4, 122.8 (CH), 123.2, 124.3 (C), 124.6, 124.7, 127.1, 129.7, 129.9 (CH), 136.1, 
138.7, 138.8, 140.4, 149.2, 149.5, 155.7, 156.8 (C). IR (KBr): v = 3026 (w), 2959, 2902, 
2865, 1600, 1512 (m), 1452 (s), 1423, 1391, 1362, 1348, 1267, 1220, 1184, 1166, 1109, 
1011 (m), 909 (s), 892, 874 (m), 833, 748, 729 (s), 691, 648, 615, 605, 559 (m) cm-1.     
MS (EI, 70 eV): m/z (%) = 432 ([M]+, 100), 418 (18), 417 (54), 201 (13), 173 (10), 57 (15). 
HRMS (EI, 70 eV): calcd for C32H32O [M]+: 432.24477; found: 432.24480. 
O
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7.1.3 Synthesis of reduced products 55a,b 
 
Diisobutyl dibenzo[b,d]furan-2,3-dicarboxylate (55a): Starting with 52 (350 mg,         
1.0 mmol), following the general procedures A, 
55a was prepared as a brownish highly viscous 
oil (378 mg, 76 %). 1H NMR (300 MHz, CDCl3):            
 = 0.83 (d, 6H, J = 6.7 Hz, 2CH3), 0.93 (d, 6H, 
J = 6.7 Hz, 2CH3), 0.94 (d, 6H, J = 6.7 Hz, 
2CH3), 1.76- 2.03 (m, 2H, 3CH), 2.75 (t, 2H,     
J = 7.4 Hz, CH2), 3.20 (t, 2H, J = 7.7 Hz, CH2),      
3.81 (d, 2H, J = 6.8 Hz, CH2O), 3.94 (d, 2H,     
J = 6.7 Hz, CH2O), 3.95 (d, 2H, J = 6.7 Hz, CH2O), 6.42 (d, 1H, J = 15.9 Hz, CH),  6.46 (d, 
1H, J = 16.1 Hz, CH), 7.38-7.52 (m, 3H, ArH), 7.69 (d, 1H, J = 16.3 Hz, CH),  7.73 (d, 1H, 
J = 16.3 Hz, CH). 13C NMR (75.5 MHz, CDCl3):   = 19.0, 19.1, 19.2 (2CH3), 22.4 (CH2), 
27.7 (CH), 27.9 (2CH), 32.0 (CH2), 70.7, 70.8, 71.0 (CH2O), 110.7 (CH), 113.1 (C), 118.2, 
118.3, 120.8, 123.8 (CH), 127.9, 131.4 (C), 134.0, 144.3 (CH), 154.7, 161.4 (C), 167.0, 
167.2, 171.7 (CO). IR (KBr): v = 3072, 2959, 2873 (m), 1719 (s), 1636, 1602, 1577 (w), 
1454, 1393, 1376, 1350, 1306 (m), 1274, 1239, 1219, 1778, 1111, 1100, 1060 (s), 1011, 
983 (m), 945, 900, 848, 881, 767 (w), 746 (m), 722, 694, 602, 564 cm-1. MS (EI, 70 eV): 
m/z (%) = 498 ([M]+, 100), 426 (16), 425 (63), 422 (10), 396 (19), 368 (11), 367 (15), 365 
(11), 350 (35), 340 (11), 339 (11), 323 (14), 322 (24), 294 (12), 267 (12), 221 (17), 57 (80), 
41 (38).  
 
 (2E,2'E)-dihexyl 3,3'-(benzofuran-2,3-
diyl)diacrylate (55b): Starting with 52 (350 mg,  
1.0 mmol), following the general procedures A, 55b 
was prepared asa brownish highly viscous oil    
(393 mg, 79 %). 1H NMR (300 MHz, CDCl3):           
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 = 1.36 (s, 9H, 3CH3), 1.48 (s, 9H, 3CH3), 1.49 (s, 9H, 3CH3), 2.63 (t, J = 7.5 Hz, 2H, 
CH2), 3.13 (t, 2H, J = 7.9 Hz, CH2), 6.33 (d, J = 15.8 Hz, 1H, CH), 6.37 (d, J = 16.5 Hz, 1H, 
CH), 7.39 (dd, J = 1.3, 8.2 Hz, 1H, ArH), 7.49 (d, J = 0.9 Hz, 1H, ArH), 7.67-7.70 (m, 3H, 
ArH/olefinic CH). IR (KBr): v = 3400, 3061 (w), 2976, 2930, 1801 (m), 1704 (s), 1635, 
1476, 1450, 1392 (m), 1367 (s), 1304, 1282 (m), 1255, 1143, 969 (s), 949, 880, 844,     
809 (m), 746 (s), 670, 632, 611, 581,  539 (m) cm-1. MS (EI, 70 eV): m/z (%) = 498 ([M]+, 
6), 494 (10), 442 (31), 436 (13), 425 (12), 387 (19), 386 (95), 380 (28), 369 (16), 331 (16), 
330 (100), 328 (13), 326 (37), 325 (10), 313 (11), 310 (15), 308 (16), 284 (28), 266 (32), 
221 (12), 188 (13), 57 (97), 41 (83).  
 
(E)-2-(2-methoxystyryl)benzofuran (54jA): 54jA was isolated as a by-product of 54j as a 
brownish highly viscous oil (37 mg, 15 %). 1H NMR (300 MHz, 
CDCl3):  =  3.96 (s, 3H, OCH3), 6.69 (s, 1H, ArH),  6.94-7.03 (m, 
2H, ArH), 7.12 (d, 1H, J = 16.3 Hz, CH), 7.19-7.33 (m, 3H, ArH), 
7.49-7.61 (m, 3H, ArH), 7.66 (d, 1H, J = 16.4 Hz, CH). 13C NMR (75.5 MHz,CDCl3):           
 = 55.5 (OCH3), 104.7, 110.9, 111.1, 117.1, 120.7, 120.8, 122.8, 124.4, 125.5 (CH), 125.6 
(C), 127.1, 129.2 (CH), 129.3, 154.9, 155.8, 157.3 (C). IR (KBr): v = 3121, 3060 (w), 2999, 
2931, 2835 (m), 1932, 1896, 1863, 1810 (w), 1592, 1578, 1551, 1481 (m), 1462, 1449, 
1433 (s), 1312, 1291 (m), 1252 , 1237 (s), 1190, 1177, 1160 (m), 1102 (s), 1047 (m), 
1027, 962, 942 (s), 932, 909, 885, 860,  845, 832 (m), 796 (s), 781 (m), 748, 740 (s), 652, 
613, 598, 572, 535 (m) cm-1. MS (EI, 70 eV): m/z (%) = 250 ([M]+, 100), 219 (20), 217 (20), 
178 (31), 144 (35). HRMS Pos (ESI) calcd for C17H14O2 [M+H]+: 250.0994; found: 
250.09884.  
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7.2  Site-Selective Suzuki Cross-Coupling Reactions of 2,3 
dibromobenzofuran 
   
General procedure for the synthesis of 58a-k, 59a-e and 61a-e: The reaction was carried 
out in a pressure tube. To a dioxane suspension (5 mL) of 1 (276 mg, 1.0 mmol), 
Pd(PPh3)4 (58 mg, 5 mol-%, 0.05 mmol) and the arylboronic acid (9) (1.0 mmol per 
coupling) was added an aqueous solution of K2CO3 (2 M, 1 mL). The mixture was heated 
at the indicated temperature (70-80 °C) under an argon atmosphere for the indicated 
period of time (6-8 h). The reaction mixture was diluted with water and extracted with 
CH2Cl2 (3 x 25 mL). The combined organic layers were dried (Na2SO4), filtered and the 
filtrate was concentrated in vacuo. The residue was purified by flash chromatography 
(silica gel, EtOAc / heptanes). 
 
7.2.1   Synthesis of 2,3-diarylbenzofurans 58a-k 
 
2,3-Diphenylbenzofuran (58a). Compound 58a was prepared from 13 
(276 mg             1.0 mmol), phenylboronic acid (244 mg, 2.0 mmol), 
according to the General procedure, as a  white solid (251 mg, 93 %). 
Reaction temperature: 80 °C. M. p. 84-85 °C. 1H NMR (300 MHz, 
CDCl3):             δ = 7.13-7.49 (m, 12H, ArH), 7.57-7.60 (m, 2H, ArH). 13C NMR (62.9 MHz, 
CDCl3):            δ = 111.1 (CH), 117.5 (C), 120.0, 122.9, 134.7, 127.0, 127.6, 128.3, 128.4, 
129.0, 129.8 (CH), 130.2, 130.7, 132.9, 150.5, 154.0 (C). IR (KBr): v = 3062, 3027, 2921, 
2852, 1602, 1568, 1558, 1498, 1487, 1472 (w), 1455, 1441 (m), 1369, 1340, 1315, 1291 
(w), 1255, 1203, 1188, 1110, 1079, 1062, 1022, 1008, 960, 917, 891, 836, 828 (m), 764, 
746, 700, 692, 676 (s), 621 (m), 608 (s), 582, 561 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 
O
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270 ([M]+, 100), 269 (19), 255 (10), 241 (21), 239 (22), 134 (9), 120 (9). HRMS (EI, 70 eV): 
calcd for      C20H14O  [M]+: 270.10392; found: 270.10393. 
 
2,3-Di-p-tolylbenzofuran (58b). Compound 58b was prepared from 13 (276 mg,           
1.0 mmol) and p-tolylboronic acid (272 mg, 2.0 mmol), according to 
the General procedure, as a  colourless highly viscous oil (274 mg, 
92 %). Reaction temperature: 80 °C. 1H NMR (300 MHz, CDCl3):    
δ = 2.27 (s, 3H, CH3), 2.36 (s, 3H, CH3), 7.05 (dd, 2H, J = 0.5,     
8.5 Hz, ArH), 7.12-7.26 (m, 4H, ArH), 7.32 (d, 2H, J = 8.1 Hz, ArH), 7.40-7.51 (m, 4H, 
ArH). 13C NMR (75.5 MHz, CDCl3):  δ = 21.4 (2CH3), 111.0 (CH), 116.8 (C), 120.0, 122.8, 
124.4, 127.0 (CH), 128.0 (C), 129.1, 129.6, 129.7 (CH), 129.9, 130.5, 137.2, 138.3, 150.7, 
153.9 (C). IR (KBr): v = 3025 (w), 2919, 2853 (m), 2731 (w), 1906, 1770, 1611 (w), 1519, 
1500 (m), 1451 (s), 1371, 1289 (m), 1255 (s), 1205, 1178, 1109 (m), 1065 (s), 1019,     
986 (m), 964 (s), 898, 838 (m), 816 (s), 785, 760 (m), 743, 719 (s), 649, 636 (m), 600 (s), 
566 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 298 ([M]+, 100), 268 (9), 255 (9). HRMS (EI, 
70 eV): calcd for C22H18O [M]+: 298.13522; found: 298.13449. 
 
2,3-Di-o-tolylbenzofuran (58c). Compound 58c was prepared from 13 (276 mg,           
1.0 mmol) and 2-methylphenylboronic acid (272 mg, 2.0 mmol), 
according to the General procedure, as a  colourless highly viscous oil 
(241 mg, 81 %). Reaction temperature: 80 °C. 1H NMR (300 MHz, 
CDCl3): δ = 2.13 (s, 3H, CH3), 2.37 (s, 3H, CH3), 7.12-7.20 (m, 1H, ArH), 
7.28-7.49 (m, 10H, ArH), 7.64 (brd, 1H, J = 8.7 Hz, ArH). 13C NMR (75.5 MHz, CDCl3):      
δ = 20.1, 20.6 (CH3), 111.3 (CH), 118.4 (C), 120.5, 122.8, 124.3, 125.6, 126.0, 127.8, 
129.0 (CH), 129.7 (C), 130.5, 130.6, 130.8, 131.0 (CH), 131.9, 137.2, 137.5, 152.6,    
154.4 (C). IR (KBr): v = 3058, 3017, 2953, 2923, 2859 (w), 1479 (m), 1450 (s), 1379, 1364, 
O
Me
Me
O
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1294, 1280 (m), 1252 (s), 1207, 1196, 1114, 1066, 1055, 1036, 1008 (m), 961 (s), 945, 
928, 899, 835 (m), 761, 743, 723 (s), 683, 666 (m), 616 (s), 590, 576, 549 (m) cm-1.      
GC-MS (EI, 70 eV): m/z (%) = 298 ([M]+, 100), 268 (9), 255 (9). HRMS (EI, 70 eV): calcd 
for C22H18O [M]+: 298.13522; found: 298.13449. 
 
2,3-Bis(4-ethylphenyl)benzofuran (58d). Compound 58d was prepared from 13        
(276 mg, 1.0 mmol) and 4-ethylphenylboronic acid (300 mg,           
2.0 mmol), according to the General procedure, as a colourless 
highly viscous oil (280 mg, 86 %). Reaction temperature: 80 °C.         
1H NMR (250 MHz, CDCl3): δ = 1.30 (t, 3H, J = 7.4 Hz, CH3), 1.38 (t, 
3H, J = 7.4 Hz, CH3), 2.69 (q, 2H, J = 7.8 Hz, CH2), 2.81 (q, 2H, J = 7.8 Hz, CH2), 7.19-
7.40 (m, 6H, ArH), 7.48-7.69 (m, 6H, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 15.3,        
15.4 (CH3), 28.7 (2CH2), 111.0 (CH), 116.9 (C), 120.0 (CH), 120.8 (C), 122.8, 124.4, 
127.0, 128.0, 128.3, 129.7 (CH), 130.2, 130.6, 143.5, 144.6, 150.7, 154.0 (C). IR (KBr):  
v = 3025 (w), 2962 (m), 2929, 2871, 1909, 1667, 1592 (w), 1519, 1499 (m), 1451 (s), 
1413, 1372, 1337, 1289, 1256, 1207, 1177, 1109 (m), 1067 (s), 1048, 1018, 1008 (m),  
963 (s), 928, 899 (m), 834 (s), 761 (m), 743(s), 691, 660, 647, 633 (m), 603 (s), 582,            
557 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 326 ([M]+, 100), 311 (34), 148 (9). HRMS (EI, 
70 eV): calcd for C24H22O [M]+: 326.16652; found: 326.16642. 
 
2,3-Bis(4-tert-butylphenyl)benzofuran (58e). Compound 58e was prepared from 13  
(276 mg, 1.0 mmol) and 4-tert-butylphenylboronic acid (356 mg,  
2.0 mmol), according to the General procedure, as a white 
crystalline solid (336 mg, 88 %). Reaction temperature: 80 °C. M. p. 
121-122 °C. 1H NMR    (250 MHz, CDCl3): δ = 1.37 (s, 9H, 3CH3), 
1.46 (s, 9H, 3CH3), 7.23-7.35(m, 2H, 13rH), 7.39 (d, 2H, J = 8.7 Hz, 
ArH), 7.51-7.60 (m, 6H, ArH), 7.71 (d, 2H, J = 8.7 Hz, ArH). 13C NMR (62.9 MHz, CDCl3):           
O
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Et
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δ = 31.3, 31.5 (3CH3), 34.7, 34.8 (C), 111.0 (CH), 116.9 (C),  120.1, 122.7, 124.4, 125.4, 
125.8, 126.6 (CH), 128.1 (C), 129.4, (CH), 129.9, 130.7, 150.4, 150.5, 151.4, 153.9 (C).  
IR (KBr): v = 3035 (w), 2960 (m), 2902, 2866, 1589 (w), 1520, 1497, 1472 (m), 1452 (s), 
1408, 1393, 1362, 1267 (m), 1257 (s), 1209 (m), 1106 (s), 1064, 1015 (m), 965 (s), 907, 
901 (m), 836 (s), 821 (m), 746, 739 (s), 625, 596, 582 (m), 547 (s) cm-1. GC-MS (EI, 70 
eV): m/z (%) = 382 ([M]+, 100), 368 (26), 367 (89), 176 (14), 148 (23), 57 (12). HRMS (EI, 
70 eV): calcd for C28H30O [M]+: 382.22912; found: 382.22904. 
 
2,3-Bis(2-chlorophenyl)benzofuran (58f). Compound 58f was prepared from 13 (276 mg 
1.0 mmol), 2-chlorophenylboronic acid (312 mg, 2.0 mmol), according to 
the General procedure, as a  white solid (294 mg,  87 %). Reaction 
temperature: 80 °C. M. p. 104-105 °C. 1H NMR (300 MHz, CDCl3):         
δ = 7.06-7.19 (m, 6H, ArH), 7.23-7.38 (m, 5H, ArH), 7.48 (dt, J = 0.7,  
8.1 Hz, 1H, ArH). 13C NMR (62.9 MHz, CDCl3):  δ = 111.5 (CH), 118.1 (C), 121.0, 123.0, 
124.9, 126.6, 126.9 (CH), 128.7 (C), 129.2 (CH), 129.9 (C), 130.1, 130.3, 130.4 (CH), 
131.4 (C), 132.2, 132.3 (CH), 134.1, 134.3, 150.4, 154.5 (C). IR (KBr): v = 3056, 1631, 
1581, 1564, 1537, 1513 (w), 1486, 1448, 1438, 1369, 1295, 1271, 1245, 1204, 1161, 
1111, 1088, 1061, 1041, 1030, 1008, 966, 949, 905, 829 (m), 760, 748, 736, 724, 713 (s), 
697, 664, 658, 613, 570 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 338 ([M]+, 94), 302 (11), 
275 (11), 269 (22), 268 (100), 240 (11), 239 (47), 237 (16), 134 (32), 120 (27), 119 (20). 
HRMS (EI, 70 eV): calcd for C20H12Cl2O  [M]+: 338.02597; found: 338.02554. 
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2,3-Bis(4-chlorophenyl)benzofuran (58g). Compound 58g was prepared from 13      
(276 mg, 1.0 mmol) and 4-chlorophenylboronic acid (312 mg,         
2.0 mmol), according to the General procedure, as a white crystalline 
solid (281 mg, 83 %). Reaction temperature: 80 °C. M. p. 102-      
103 °C. 1H NMR (300 MHz, CDCl3): δ = 7.15-7.39 (m, 9H, ArH), 7.45-
7.51 (m, 3H, ArH).  13C NMR (75.5 MHz, CDCl3): δ = 111.3 (CH), 101.8, 116.8 (C), 119.9, 
123.3, 125.2, 128.2, 128.5, 129.2 (CH), 129.8, 133.8, 134.5, 149.7, 154.0 (C), 131.0 (CH).            
IR (KBr): v = 3078, 3054, 3037, 2923, 2852 (w), 1581 (m), 1558 (w), 1497, 1484 (m),  
1449 (s), 1401, 1373, 1289 (w), 1253, 1201, 1174 (m), 1089, 1066, 1011, 963 (s), 945, 
930, 919, 899 (m), 832, 821, 811 (s), 760 (m), 749, 742, 720 (s), 682, 646, 631, 624, 616, 
582 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 338 ([M]+, 100), 302 (11), 268 (27), 239 (29), 
134 (20), 120 (20), 119 (12). HRMS (EI, 70 eV): calcd for C20H12Cl2O [M]+: 338.02597; 
found: 338.02559. 
 
2,3-Bis(4-fluorophenyl)benzofuran (58h). Compound 58h was prepared from 13       
(276 mg, 1.0 mmol) and 4-fluorophenylboronic acid (280 mg,          
2.0 mmol), according to the General procedure, as a white crystalline 
solid (248 mg, 81 %). Reaction temperature: 80 °C. M. p. 80-81 °C.  
1H NMR (250 MHz, CDCl3): δ = 6.88-6.95 (m, 2H, ArH), 7.03-7.27 (m, 
4H, ArH), 7.31-7.64 (m, 6H, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 111.2 (CH), 115.6 (d, 
JF,C = 21.2 Hz, CH), 116.2 (d, JF,C = 21.6 Hz, CH), 119.8, 123.1, 124.9 (CH), 127.7 (d, JF,C 
= 3.3 Hz, C), 128.6 (d, JF,C = 3.5 Hz, C), 128.8 (d, JF,C = 8.2 Hz, CH), 130.1 (C), 131.4 (d, 
JF,C = 8.0 Hz, CH), 149.8, 153.9 (C), 162.4 (d,    JF,C = 247.2 Hz, CF), 162.5 (d, JF,C = 
249.5 Hz, CF). IR (KBr): v = 3067, 3045, 3016, 2925, 2852 (w), 1594, 1582, 1515 (m), 
1498, 1450 (s), 1409, 1374, 1338, 1302, 1254 (m),    1223 (s), 1205, 1161, 1155, 1109, 
1099, 1088, 1068, 1014, 1009, 965, 934 (m),  836, 821, 814 (s), 802, 794 (m), 749 (s), 
O
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720, 686, 665, 627 (m), 598 (s), 580 (m), 564, 536 (s) cm-1. GC-MS (EI, 70 eV):             
m/z (%) = 306 ([M]+, 100), 305 (9), 277 (18), 275 (13). HRMS (EI, 70 eV): calcd for 
C20H12F2O [M]+: 306.08507; found: 306.08454. 
 
2,3-Bis(2-methoxyphenyl)benzofuran (58i). Compound 58i was prepared from 13    
(276 mg 1.0 mmol), 2-methoxyphenylboronic acid (304 mg, 2.0 mmol), 
according to the General procedure, as a white solid (270 mg, 82 %). 
Reaction temperature: 80 °C. M. p. 78-79 °C. 1H NMR (300 MHz, 
CDCl3): δ = 3.48 (s, 3H, OCH3), 3.67 (s, 3H, OCH3), 6.90 (d, 1H,            
J = 8.3 Hz, ArH), 6.97-7.06 (m, 3H, ArH), 7.26-7.40 (m, 5H, ArH), 7.56-7.64 (m, 3H, ArH). 
13C NMR (75.5 MHz, CDCl3): δ = 55.0, 55.2 (OCH3), 111.0, 111.1, 111.2 (CH), 115.9 (C), 
120.4, 120.5 (CH), 120.9 (C), 121.0, 122.4 (CH), 123.0 (C), 124.0, 128.5 (CH), 129.7 (C), 
130.1, 130.7, 130.9 (CH), 149.9, 154.5, 157.0, 157.1 (C). IR (KBr): v = 3062, 2998,      
2934 (w), 2833 (m), 1600, 1586, 1499, 1486 (m), 1459, 1447, 1433 (s), 1368 (w),        
1289 (m), 1242 (s), 1203, 1194, 1178, 1161, 1115, 1054, 1041 (m), 1024, 962 (s), 907, 
899, 793, 785 (m), 743 (s), 696, 666, 647, 602, 615, 591, 570, 559, 536 (m) cm-1.         
GC-MS (EI, 70 eV): m/z (%) = 330 ([M]+, 100), 271 (9), 255 (14), 121 (12). HRMS (EI, 70 
eV): calcd for C22H18O3 [M]+: 330.12505; found: 330.12479. 
 
2,3-Bis(2,5-dimethoxyphenyl)benzofuran (58j). Compound 58j was prepared from 13 
(274 mg 1.0 mmol), 2,5-dimethoxyphenylboronic acid (364 mg,  
2.0 mmol), according to the General procedure, as a  lightly brown 
solid (331 mg, 85 %). Reaction temperature: 80 °C. M. p. 79-80 °C. 
1H NMR (300 MHz, CDCl3): δ = 3.46 (s, 3H, OCH3), 3.62 (s, 3H, 
OCH3), 3.73 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 6.82-6.96 (m, 5H, ArH), 7.18-7.38 (m, 3H, 
ArH), 7.56-7.63 (m, 2H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 55.7, 55.8, 55.9 (OCH3), 
111.2, 112.3, 112.7, 113.5, 115.6, 115.8 (CH), 115.9 (C), 116.6, 121.0 (CH), 121.3 (C), 
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122.5 (CH), 123.8 (C), 124.1 (CH), 129.5, 149.8, 151.4, 151.5, 153.4, 153.6, 154.4 (C).   
IR (KBr): v = 3057, 2995, 2934, 2903 (w), 2831 (m), 1606, 1581 (w), 1492, 1453 (s),    
1421 (m), 1359 (w), 1306, 1293, 1270, 1245 (m), 1216, 1175 (s), 1160 (m), 1042, 1022 
(s), 991, 927, 909, 873, 861, 849, 799, 768 (m), 730 (s), 691, 647, 626, 611, 573,          
556 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 390 ([M]+, 100), 345 (15), 344 (47), 301 (14), 
172 (9). HRMS (EI, 70 eV): calcd for C24H22O5  [M]+: 390.14618; found: 390.14603. 
 
2,3-Bis(3,5-dimethylphenyl)benzofuran (58k). Compound 58k was prepared from 13 
(276 mg 1.0 mmol), 3,5-dimethylphenylboronic acid (300 mg,        
2.0 mmol), according to the General procedure, as a white solid 
(258 mg, 79 %). Reaction temperature: 80 °C. M. p. 106-107 °C.      
1H NMR (250 MHz, CDCl3): δ = 2.18 (s, 6H, 2CH3), 2,27 (s, 6H, 
2CH3), 6.85 (s, 1H, ArH), 6.85 (s, 1H, ArH), 6.02 (s, 2H, ArH), 7.11-
7.20 (m, 4H, ArH), 7.41-7.47 (m, 2H, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 21.3,        
21.4 (2CH3), 111.0 (CH), 117.5 (C), 120.1, 120.7, 124.4, 124.7, 127.4, 129.2, 130.0 (CH), 
130.4, 130.6, 132.7, 167.8, 168.3, 150.6, 153.9 (C). IR (KBr): v = 3011, 2913, 2855, 2730, 
2142 (w), 1600, 1582 (m), 1566, 1503 (w), 1454, 1377, 1338, 1259, 1234, 1192, 1182, 
1169, 1159, 1097, 1054, 1037, 1009 (m), 976, 947 (w), 924, 896 885, 873 (m), 856,      
845 (s), 811, 757 (m), 738, 703, 680 (s), 628 (m), 591, 541, 534 (w) cm-1. GC-MS (EI,     
70 eV): m/z (%) = 326 ([M]+, 100), 296 (5), 252 (4). HRMS (EI, 70 eV): calcd for C24H22O 
[M]+: 326.16652; found: 326.16664. 
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7.2.2 Synthesis of 2-aryl-3-bromobenzofuran 59a-e 
 
3-Bromo-2-p-tolylbenzofuran (59a). Compound 59a was prepared from 13 (276 mg    
1.0 mmol), p-tolylboronic acid (136 mg, 1.0 mmol), according to the 
General procedure, as a  white solid (265 mg, 93 %). Reaction 
temperature: 70 °C. M. p. 81-82 °C. 1H NMR (300 MHz, CDCl3):      
δ = 2.26 (s, 3H, CH3), 7.03-7.26 (m, 4H, ArH), 7.51-7.60 (m, 2H, ArH), 8.10 (d, 2H,            
J = 8.3 Hz, ArH). 13C NMR (75.5 MHz, CDCl3):  δ = 21.5 (CH3), 93.1 (C), 111.2, 119.8, 
123.4, 125.4, 126.7, 129.3 (CH), 129.4, 139.2, 150.6, 153.1 (C). IR (KBr): v = 3030, 2967, 
2917, 2858 (w), 1502 (m), 1450 (s), 1412, 1342, 1325, 1303, 1271, 1252, 1203, 1189, 
1175, 1107 (m), 1073 (s), 1018, 1007 (m), 985 (s), 932, 889, 830 (m), 816 (s), 785 (m),  
739 (s), 712, 653, 632, 574, 537 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 288 ([M, 81Br]+, 
100), 286 ([M, 79Br]+, 100), 207 (10), 179 (30), 178 (33), 152 (10), 89 (11), 76 (9), 237 (16), 
134 (32), 120 (27), 119 (20). HRMS (EI, 70 eV): calcd for C15H11Br O [M, 79Br]+: 
285.99878; found: 285.99869. 
 
3-Bromo-2-(4-ethylphenyl)benzofuran (59b). Compound 59b was prepared from 13 
(276 mg 1.0 mmol), 4-ethylphenylboronic acid (150 mg, 1.0 mmol), 
according to the General procedure, as a white solid   (258 mg, 86 
%). Reaction temperature: 70 °C. M. p. 89-90 °C. 1H NMR (250 MHz, 
CDCl3): δ = 1.19 (t, 1H, J = 7.6 Hz, CH3), 2.62 (q, 2H, J = 7.6 Hz, CH2), 7.18-7.28 (m, 4H, 
ArH), 7.38-7.48 (m, 2H, ArH), 8.00 (d, 2H, J = 8.4 Hz, CH3). 13C NMR (62.9 MHz, CDCl3): 
δ = 15.4 (CH3), 28.8 (CH2), 93.1 (C), 111.2, 119.7, 123.4, 125.3, 126.8 (CH), 127.0 (C), 
128.1 (CH), 129.7, 145.5, 150.6, 153.1 (C). IR (KBr): v = 3028 (w), 2962, 2927 (m), 2871, 
2422, 1907, 1771, 1714, 1666, 1612, 1590 (w), 1502 (m), 1449 (s), 1416, 1345, 1319, 
1297, 1272, 1254, 1205, 1185, 1108 (m), 1073 (s), 1049, 1018, 1006 (m), 985 (s), 926, 
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890 (m), 831, 738 (s), 659, 642, 631, 579, 552 (m) cm-1. GC-MS (EI, 70 eV):                  
m/z (%) = 302 ([M]+, 81Br, 3), 300 ([M, 79Br]+, 2), 298 (100), 255 (11), 178 (9). HRMS (EI, 
70 eV): calcd for C16H13BrO [M, 79B]+: 300.015065; found: 300.015364. 
 
3-Bromo-2-(4-chlorophenyl)benzofuran (59c). Compound 59c was prepared from 13 
(138 mg 0.5 mmol), 4-chlorophenylboronic acid (156 mg, 1.0 mmol), 
according to the General procedure, as a  white solid (138 mg,        
90 %). Reaction temperature: 70 °C. M. p. 114- 115 °C.                          
1H NMR (300 MHz, CDCl3): δ = 7.33-7.60 (m, 6H, ArH), 8.14 (d, 2H, J = 8.9 Hz, ArH).    
13C NMR (62.9 MHz, CDCl3): δ = 94.3 (C), 111.3, 120.0, 123.6, 125.9, 127.9 (CH),     
128.0 (C), 128.9 (CH), 134.9, 149.2, 153.1 129.4 (C). IR (KBr): v = 3066 (w), 1889, 1769, 
1714, 1594, 1556 (w), 1485, 1474 (m), 1449 (s), 1416, 1403, 1342, 1320, 1300, 1268, 
1249, 1201 (m), 1177, 1111 (w), 1093, 1068 (s), 1011 (m), 986 (s), 928, 903, 889 (m),  
822 (s), 814 (m), 737, 721 (s), 758, 648, 625, 600, 573 (m) cm-1. GC-MS (EI, 70 eV):     
m/z (%) = 308 ([M, 81Br or 37Cl]+, 100), 306 ([M, 79Br]+, 35Cl 77), 201 (12), 199 (36), 164 
(15), 163 (27), 99 (10), 82 (9). HRMS (EI, 70 eV): calcd for C14H8BrClO  [M, 79Br, 35Cl]+: 
305.94416; found: 305.94395. 
 
3-Bromo-2-(2-methoxyphenyl)benzofuran (59d). Compound 59d was prepared from 13 
(138 mg, 0.5 mmol) and 2-methoxyphenylboronic acid (152 mg,          
1.0 mmol), according to the General procedure, as white solid (181 mg, 
87 %). Reaction temperature: 70 °C. M. p. 86-87 °C. 1H NMR (300 MHz, 
CDCl3): δ = 3.77 (s, 3H, OCH3), 6.91-7.00 (m, 2H, ArH), 7.19-7.24 (m, 2H, ArH), 7.24- 
7.28 (m, 2H, ArH ), 7.31-7.33 (m, 2H, ArH). 13C NMR (75 MHz, CDCl3):  δ = 55.7 (OCH3), 
96.7 (C), 111.5, 111.6 (CH), 118.3 (C), 119.8, 120.5, 123.3, 125.2 (CH), 129.0 (C), 131.4, 
131.7 (CH), 150.5, 153.9, 157.7 (C). IR (KBr): v = 3062, 3037, 3003, 2959, 2934, 2835 (w), 
1610, 1586 (m), 1485 (s), 1461 (m), 1446, 1433 (s), 1313, 1296 (m), 1255, 1243 (s), 1200, 
O
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1180, 1162, 1120, 1107, 1073 (m), 1057, 1043, 1023, 984 (s), 932, 891, 827, 781 (m),  
739 (s), 667, 636, 588, 554 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 304 ([M, 81Br]+, 84), 
302 ([M, 79Br]+, 86), 223 (22), 209 (28), 208 (100), 167 (12), 165 (24), 152 (30), 151 (17). 
HRMS (EI, 70 eV): calcd for C15H11BrO2 [M, 79Br]+: 301.99369; found: 301.99370. 
 
3-Bromo-2-(3,5-dimethylphenyl)benzofuran (59e). Compound 59e was prepared from 
13 (276 mg, 1.0 mmol), 3,5-dimethylphenylboronic acid (150 mg,  
1.0 mmol), according to the General procedure, as a white solid  
(237 mg, 79 %). Reaction temperature: 70 °C. M. p. 95-96 °C.           
1H NMR (250 MHz, CDCl3): δ = 2.45 (s, 6H, 2CH3), 7.08 (s, 1H, ArH), 7.31-7.41 (m, 2H, 
ArH), 7.51-7.60 (m, 2H, ArH), 7.82 (s, 2H, ArH). 13C NMR (62.9 MHz, CDCl3):                  
δ = 21.5 (2CH3), 93.6 (C), 111.2, 119.8, 123.4, 124.6, 125.4 (CH), 129.4, 129.7 (C),   
130.9 (CH), 138.2, 150.7, 153.1 (C). IR (KBr): v = 3063, 3037, 2947 (w), 2916 (m), 2855, 
2724, 1925, 1888, 1767, 1740 (w), 1602, 1558 (m), 1451 (s), 1419, 1371, 1343, 1319, 
1302, 1263, 1229, 1190, 1176, 1148, 1115, 1099 (m), 1019 (s), 1006, 980, 949, 926, 894, 
872, 862 (m), 848 (s), 755 (m), 740, 692 (s), 662, 639, 592, 539, 531 (m) cm-1. GC-MS (EI, 
70 eV): m/z (%) = 302 ([M, 81Br]+, 99), 300 ([M, 79Br]+, 100), 193 (17), 178 (19). HRMS (EI, 
70 eV): calcd for C16H13BrO [M, 79Br]+: 300.01443; found: 300.01422. 
 
3-Bromo-2-(2,6-dimethoxyphenyl)benzofuran (59f). Compound 59f was prepared from 
13 (276 mg 1.0 mmol), 2,6-dimethoxyphenylboronic acid (182 mg,     
1.0 mmol), according to the General procedure, as a white solid      (295 
mg, 89 %). Reaction temperature: 70 °C. M. p. 79- 80 °C.           1H 
NMR (300 MHz, CDCl3): δ = 3.72 (s, 3H, OCH3), 6.57 (d, J = 8.47, 2H, ArH), 7.11-  7.53 
(m, 5H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 56.2 (2OCH3), 98.8 (C), 104.0, 111.6, 
119.5 (CH), 120.7 (C), 122.9, 124.7 (CH), 128.7 (C), 132.2 (CH), 154.3, 159.2, 159.7 (C). 
IR (KBr): v = 3056, 3003, 2961, 2936, 2837 (w), 1619, 1587 (m), 1473 (s), 1448 (m),   
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1431 (s), 1297 (m), 1247 (s), 1202, 1134 (m), 1106 (s), 1050, 1031, 1012, 986, 919, 906 
890, 820, 781, 748 (m), 728 (s), 693, 637, 591, 556 (m) cm-1. GC-MS (EI, 70 eV):          
m/z (%) = 334 ([M, 81Br]+, 100), 332 ([M, 79Br]+, 100), 238 (29), 237 (16), 223 (78), 165 (9), 
152 (11), 147 (42), 139 (16), 131 (20). HRMS (EI, 70 eV): calcd for C16H13BrO3 [M, 79Br]+: 
332.00426; found: 332.00332. 
 
2-(Biphenyl-3-yl)-3-bromobenzofuran (59g). Compound 59g was prepared from 13 (276 
mg 1.0 mmol), biphenyl-3-ylboronic acid (198 mg, 1.0 mmol), according 
to the General procedure, as a  white solid (233 mg, 67 %). Reaction 
temperature: 70 °C. M. p. 78-79 °C. 1H NMR (300 MHz, CDCl3):             
δ = 7.22-7.62 (m, 11H, ArH), 8.08 (dt, 1H, J = 1.5, 7.7 Hz, ArH), 8.33 (t, 
1H, J = 1.4 Hz, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 94.16 (C), 111.3, 120.0, 123.6, 
125.5, 125.6, 125.7, 127.3, 127.7, 127.8, 128.9, 129.1 (CH), 129.6, 130.0, 140.7, 141.7, 
150.3, 153.2 (C). IR (KBr): v = 3053, 3031 (m), 2918, 2849, 2790, 2682, 2351, 1953, 1894, 
1811, 1705, 1674 (w), 1593, 1573, 1472 (m), 1453 (s), 1401, 1341, 1299, 1265, 1198, 
1173, 1113 (m), 1071 (s), 1051, 1024, 1007 (m), 988 (s), 893, 843, 810 (m), 757, 741, 
690, 671 (s), 640, 613, 577, 569 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 350 ([M, 81Br]+, 
99), 348 ([M, 79Br]+, 100), 241 (21), 239 (36), 119 (10). HRMS (EI, 70 eV): calcd for 
C20H13BrO [M, 79Br]+: 348.01443; found: 348.01390. 
 
3-Bromo-2-(thiophen-2-yl)benzofuran (59h). Compound 59h was prepared from 13  
(276 mg 1.0 mmol), thiophen-2-ylboronic acid (128 mg, 1.0 mmol), 
according to the General procedure, as a  white solid (154 mg, 10 %). 
Reaction temperature: 70 °C. M. p. 194-195 °C. 1H NMR (250 MHz, 
CDCl3): δ = 6.98-7.02 (m, 1H, ArH), 7.08-7.21 (m, 2H, ArH), 7.27-7.37 (m, 3H, ArH),    
7.69 (dd, 1H, J = 0.8, 3.7 Hz, ArH). 13C NMR (75.5 MHz, CDCl3):  δ = 93.0 (C), 111.2, 
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119.6, 123.7, 125.6, 126.6, 127.0, 127.7 (CH), 129.3, 131.3, 147.5, 153.1 (C). IR (KBr):  
v = 3097, 3071, 3034, 3016, 1932, 1895, 1779, 1667, 1551 (w), 1586 (m), 1494, 1471 (w), 
1448 (s), 1420, 1362, 1341, 1303, 1270, 1254, 1223, 1206, 1194, 1171, 1148, 1082 (m), 
1064, 1031 (s), 1004, 970, 887, 877, 848, 824, 791 (m), 741, 694 (s), 657, 634, 574,     
547 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 280 ([M, 81Br]+, 100), 278 ([M, 79Br]+, 98), 171 
(59), 139 (9), 127 (14), 85 (18). HRMS (EI, 70 eV): calcd for C12H7BrOS [M, 79Br]+: 
277.93955; found: 277.93989. 
 
2-p-Tolylbenzofuran (60a). Compound 60a was obtained as a by-product of 58a (9.0 mg, 
4.1 %). 1H NMR (300 MHz, CDCl3): δ = 2.32 (s, 3H, CH3), 7.11-
7.21 (m, 5H, ArH), 7.41-7.50 (m, 2H, ArH), 7.66-7.70 (m, 2H, 
ArH). 13C NMR (75.5 MHz, CDCl3): δ = 20.8 (CH3), 100.0, 110.5, 120.1, 122.2, 123.4, 
124.3 (CH), 127.2, 128.7 (C), 128.9 (CH), 138.0, 154.2, 155.6 (C). IR (KBr): v = 3060, 
2953, 2928, 2865, 1923, 1847, 1809, 1771, 1667, 1604, 1575 (w), 1488, 1473 (m),     
1449 (s), 1379, 1356, 1311, 1285 (w), 1254 (s), 11207, 1170, 1119, 1107 (m), 1054, 1034 
(w), 1017 (s), 920, 885, 803 (m), 760, 744, 737, 718 (s), 662, 614, 572, 555, 530 (m) cm-1. 
GC-MS (EI, 70 eV): m/z (%) = 208 ([M]+, 100), 207 (74), 189 (16), 179 (18), 178 (27), 165 
(12), 115 (10), 89 (14). HRMS (EI, 70 eV): calcd for C15H12O  [M]+: 208.08827; found: 
208.087597. 
 
2-o-Tolylbenzofuran (60c). Compound 60c was obtained as a by-product of 58c (19 mg, 
9.1 %). 1H NMR (250 MHz, CDCl3): δ = 2.61 (s, 3H, CH3), 6.92 (s, 1H, 
ArH), 7.23-7.37 (m, 5H, ArH), 7.53-7.65 (m, 2H, ArH), 7.85-7.89 (m, 1H, 
ArH). 13C NMR (62.9 MHz, CDCl3): δ = 21.9 (CH3), 105.1, 111.1, 120.9, 
122.8, 124.2, 126.1, 128.2, 128.5 (CH), 129.2, 129.9 (C), 131.3 (CH), 135.8, 154.4,    
155.7 (C). IR (KBr): v = 3060, 2953, 2928, 2865, 1923, 1847, 1809, 1771, 1667, 1604, 
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1575 (w), 1488, 1473 (m), 1449 (s), 1379, 1356, 1311, 1285 (w), 1254 (s), 11207, 1170, 
1119, 1107 (m), 1054, 1034 (w), 1017 (s), 920, 885, 803 (m), 760, 744, 737, 718 (s), 662, 
614, 572, 555, 530 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 208 ([M]+, 100), 207 (74), 189 
(16), 179 (18), 178 (27), 165 (12), 115 (10), 89 (14). HRMS (EI, 70 eV): calcd for    
C15H12O  [M]+: 208.08827; found: 208.08759. 
 
2-(Biphenyl-3-yl)benzofuran (60g). Compound 60g was obtained as a by-product of 58g 
(62 mg, 23 %). 1H NMR (300 MHz, CDCl3): δ = 7.01 (s, 1H, ArH), 7.13-
7.61 (m, 11H, ArH), 7.77 (dt, J = 1.6, 7.5 Hz, 1H, ArH), 8.02 (t, J = 1.7 
Hz, 1H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 101.6, 111.2, 121.0, 
123.0, 123.7, 123.8, 124.4, 127.2, 127.4, 127.6, 128.9 (CH), 129.2 (C), 
129.3 (CH) 131.0, 140.9, 141.9, 155.0, 155.9 (C). IR (KBr): v = 3119, 3053, 3026 (w), 
1598, 1556, 1471, 1453, 1421 (m), 1391 (w), 1347, 1305, 1253, 1200, 1167 (m), 1144, 
1107, 1095, 1074, 1056 (w), 1036 (m), 1018, 1004, 967 (w), 925, 892, 882, 820, 809 (m), 
795, 760, 748, 740, 693, 675 (s), 617, 609, 578, 560, 537 (m) cm-1. GC-MS (EI, 70 eV): 
m/z (%) = 270 ([M]+, 100), 241 (9), 239 (14), 135 (10). HRMS (EI, 70 eV): calcd for 
C20H14O  [M]+: 270.10392; found: 270.10402. 
 
2-(Thiophen-2-yl)benzofuran (60h). Compound 60h was obtained as a by-product of 58h 
(30 mg, 15 %). 1H NMR (250 MHz, CDCl3): δ = 6.88 (d,J = 0.8 Hz, 1H, 
ArH), 7.12 (dd, J = 3.7, 5.1 Hz, 1H, ArH), 7.20-7.36 (m, 3H, ArH), 7.49-
7.58 (m, 3H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 101.1, 111.1, 120.8, 
123.1, 124.3, 124.6, 125.8, 127.9 (CH), 129.1, 133.3, 151.3, 154.6 (C). IR (KBr): v = 3097, 
3071, 3034, 3016, 1932, 1895, 1779, 1667, 1551 (w), 1586 (m), 1494, 1471 (w), 1448 (s), 
1420, 1362, 1341, 1303, 1270, 1254, 1223, 1206, 1194, 1171, 1148, 1082 (m), 1064, 
1031 (s), 1004, 970, 887, 877, 848, 824, 791 (m), 741, 694 (s), 657, 634, 574,               
547 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 280 ([M, 81Br]+, 100), 278 ([M, 79Br]+, 100), 
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171 (59), 139 (9), 127 (14), 85 (18). HRMS (EI, 70 eV): calcd for C12H7OBrS [M, 79Br]+: 
277.93955; found: 277.939899. 
 
2-(2,5-Dimethoxyphenyl)benzofuran (60j).  Compound 60j was obtained as a by-product 
of 58j (20 mg, 8.1 %). 1H NMR (250 MHz, CDCl3): δ = 3.80 (s, 3H, 
OCH3), 3.88 (s, 3H, OCH3), 6.77-6.88 (m, 2H, ArH), 7.10-7.25 (m, 
2H, ArH), 7.30 (d, J = 0.8 Hz, 1H, ArH), 7.42-7.56 (m, 3H, ArH). 
13C NMR (62.9 MHz, CDCl3): δ = 54.9 (OCH3), 55.0 (OCH3), 105.6, 
109.8, 110.9, 111.4, 113.8 (CH), 118.9 (C), 120.1, 121.7, 123.2 (CH), 127.5, 150.0, 150.1 
152.7, 152.8 (C). IR (KBr): v = 3060, 2996, 2946, 2931, 2904, 2831, 2495, 2349, 2068, 
1613, 1584 (w), 1567 (m), 1500, 1453 (s), 1438 (m), 1347, 1322 (w), 1301 (m), 1273, 
1259, 1242 (m), 1219, 1197 (s), 1180, 1160, 1132, 1122, 1108 (m), 1045, 1024 (s), 940, 
868 (m), 809, 733 (s), 695, 666, 614, 540 (m) cm-1. GC-MS (EI, 70 eV):                  
m/z (%) = 254 ([M]+, 100), 240 (16), 239 (96), 211 (16), 196 (13), 168 (18), 142 (14), 127 
(9).  
 
2-Phenylbenzofuran (60l).  Compound 60l was obtained as a by-product of 58l (08 mg, 
04 %). 1H NMR (300 MHz, CDCl3): δ = 6.95 (d, J = 0.8 Hz, 1H, ArH), 
7.12-7.31 (m, 3H, ArH), 7.35-7.53 (m, 4H, ArH), 7.78-7.81 (m, 2H, 
ArH). 13C NMR (75.5 MHz, CDCl3):  δ  = 101.3, 111.2, 120.9, 122.9, 124.3, 125.0 (CH), 
127.5 (C), 128.6, 128.8 (CH), 130.5, 154.9, 154.9 (C).  
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7.2.3   Synthesis of unsymmetrical 2,3-diarylbenzofurans 61a-e 
 
3-(3-Methoxyphenyl)-2-p-tolylbenzofuran (61a). Compound 61a was prepared from 13 
(276 mg, 1.0 mmol), p-tolylboronic acid (136 mg, 1.0 mmol),          
3-methoxyphenylboronic acid (152 mg, 1.0 mmol), according to the 
General procedure (with one-pot stratergy and p-tolylboronic acid 
was added first; the yield was calculated over 2 steps), as a white 
solid (238 mg, 76 %). Reaction temperature: 70-80 °C. M. p. 73-74 °C. 1H NMR (300 MHz, 
CDCl3): δ = 2.24 (s, 3H, CH3), 3.69 (s, 3H, OCH3), 6.82-6.86 (m, 1H, ArH), 6.95-7.12 (m, 
4H), ArH), 7.14-7.25 (m, 3H, ArH ), 7.39-7.50 (m, 4H, ArH). 13C NMR (75.5 MHz, CDCl3):         
δ = 21.4 (CH3), 55.3 (OCH3), 111.1, 113.4, 115.1 (CH), 116.7 (C), 120.0, 122.3, 122.9, 
124.5, 127.0 (CH), 127.8 (C), 129.2, 130.0 (CH), 130.3, 134.4, 138.5, 150.9, 153.9,    
160.1 (C). IR (KBr): v = 3031, 2997, 2917, 2832 (w), 1607, 1592, 1574, 1512, 1484 (m), 
1451 (s), 1427, 1369, 1314, 1282 (m), 1246, 1234 (s), 1205, 1184, 1156, 1064 (m),     
1042 (s), 1019, 1009, 987, 876, 838 (m), 819 (s), 779 (m), 742, 701 (s), 618, 610, 587, 
563, 537 (m) cm-1. GC-MS (EI, 70 eV):   m/z (%) = 314 ([M]+, 100), 271 (9), 255 (14),    
121 (12). HRMS (EI, 70 eV): calcd for C22H14O2  [M]+: 314.1307; found: 314.12999. 
 
3-(4-Fluorophenyl)-2-p-tolylbenzofuran (61b): Compound 61b was prepared from 13 
(276 mg 1.0 mmol), p-tolylboronic acid (136 mg, 1.0 mmol),       
4-fluorophenylboronic acid (154 mg, 1.1 mmol), according to the 
General procedure (with one-pot stratergy and p-tolylboronic acid 
was added first; the yield was calculated over 2 steps), as a white 
crystalline solid (244 mg, 79 %). Reaction temperature: 70 °C. M. p. 103-104 °C.                  
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1H NMR (300 MHz, CDCl3): δ = 2.41 (s, 3H, CH3), 7.17- 7.31 (m, 5H, ArH), 7.35-          
7.40 (m, 1H, ArH), 7.50-7.54 (m, 3H, ArH ), 7.57-7.61 (m, 3H, ArH). 19F NMR (282.4 MHz, 
CDCl3): δ = -114.35. 13C NMR (62.9 MHz, CDCl3): δ = 21.4 (CH3), 111.1 (CH), 115.8 (C), 
116.1 (d, JF,C = 21.0 Hz), 119.6, 123.0, 124.6, 127.0 (CH), 127.7, 128.9 (d, JF,C = 3.3 Hz) 
(C), 129.2 (CH), 130.2 (C), 131.4 (d, JF,C = 8.1 Hz) (CH), 136.6, 151.1, 153.9, 162.3 (d, 
JF,C = 246.7 Hz) (C). IR (KBr): v = 3066, 3036, 2918, 2853, 2790, 1613, 1601, 1557 (w), 
1515, 1495 (m), 1452 (s), 1432, 1371, 1337, 1292 (3), 1254, 1230, 1216, 1205, 1196, 
1182, 1156, 1091, 1066 (s), 1037, 1020, 1008, 964, 930, 897 (m), 842, 817, 811, 744 (s), 
718, 716, 663, 598, 564 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 302 ([M]+, 100), 286 (10), 
259 (9), 257 (10). HRMS (EI, 70 eV): calcd for C21H15FO  [M]+: 302.11014;                 
found: 302.11031. 
 
2,3,5-Tris(4-fluorophenyl)benzofuran (62). Compound 62 was prepared from 13       
(174 mg, 0.6 mmol) and 4-fluorophenylboronic acid     
(280 mg, 2.0 mmol), according to the General procedure, 
as a colourless highly viscous oil (162 mg, 81 %). 
Reaction temperature: 90 °C. 1H NMR (300 MHz, CDCl3): 
δ = 6.42-6.67 (m, 6H, ArH), 6.86-7.06 (m, 9H, ArH). 19F NMR (282.4 MHz, CDCl3):            
δ = -116.8, -114.3, -112.3. 13C NMR (62.9 MHz, CDCl3):  δ = 111.2 (CH), 115.6 (d,        
JF,C = 21.2 Hz, CH), 116.2 (d, JF,C = 21.6 Hz, CH),  119.8, 123.1, 124.9 (CH), 127.7 (d,  
JF,C = 3.3 Hz, C),   128.6 (d, JF,C = 3.5 Hz, C), 128.8 (d, JF,C = 8.2 Hz, CH), 130.1 (C), 
131.4 (d, JF,C = 8.0 Hz, CH), 149.8, 153.9 (C), 1162.3 (d, JF,C = 247.0 Hz, CF), 1162.4 (d, 
JF,C = 247.2 Hz, CF), 1162.5 (d, JF,C = 249.5 Hz, CF). IR (KBr): v = 3067, 3045, 3016, 
2925, 2852 (w), 1594, 1582, 1515 (m), 1498, 1450 (s), 1409, 1374, 1338, 1302, 1254 (m), 
O
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1223 (s), 1205, 1161, 1155, 1589, 1099, 1088, 1068, 1014, 1009, 965, 934 (m),  836, 821, 
814 (s), 802, 794 (m), 749 (s), 720, 686, 665, 627 (m), 598 (s), 580 (m), 564, 536 (s) cm-1. 
GC-MS (EI, 70 eV): m/z (%) = 400 ([M]+, 100), 371 (7), 275 (8). HRMS (EI, 70 eV): calcd 
for C26H15F3O [M]+: 400.10695; found: 400.10681. 
 
3,5-Dibromo-2-p-tolylbenzofuran (63). Compound 63 was prepared from 13 (138 mg, 
0.5 mmol), p-tolylboronic acid (68 mg, 0.5 mmol), according to 
the General procedure, as a  white solid (143 mg, 79 %). 
Reaction temperature: 70 °C. M. p. 114-115 °C. 1H NMR (250 MHz, CDCl3): δ = 2.43 (s, 
3H, CH3), 7.16-7.37 (m, 4H, ArH), 7.58-7.70 (m, 1H, ArH), 7.91-7.98 (m, 2H, ArH).         
13C NMR (62.9 MHz, CDCl3): δ = 21.5 (CH3), 92.0 (C), 112.7 (CH), 116.3 (C) 122.5 (CH), 
123.8, 126.2 (C), 126.8, 128.2, 129.4 (CH), 131.6, 139.7, 151.8 (C). IR (KBr): v = 3086, 
3027, 2917, 2853, 2723, 1907, 1855, 1714, 1608, 1575 (w), 1500, 1461 (m), 1450,     
1435 (s), 1409, 1390, 1325, 1298, 1257, 1203, 1191, 1186, 1133, 1112 (m), 1071 (s), 
1050, 1017 (m), 986 (s), 902 (m), 858 (s), 833 (m), 813, 794 (s), 735, 710, 683 (m),       
655 (s), 640, 593, 580, 551, 532 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 368 ([M, 81Br, 
81Br ]+, 49), 366 ([M, 81Br, 79Br]+, 100), 364 ([M, 79Br, 79Br]+, 52), 259 (13), 257 (14), 177 
(10), 176 (12). HRMS (EI, 70 eV): calcd for C15H10OBr  [M, 79Br, 79Br]+: 363.90929;    
found: 363.90898. 
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7.3   One-Pot Synthesis of 2,3-Diarylindenones by Site-Selective Suzuki-
Miyaura Reactions of 1,2-Dibromoindenone  
  
General procedure A: In a pressure tube to a suspension of 2,3-dibromoindenone 23  (144 
mg, 0.5 mmol), tetrakis (triphenylphosphine) palladium (0) (2.5-3.0 mol-% per cross-
coupling) and boronic acid (0.5 to 0.55 mmol per cross-coupling) in dioxane (5 mL) was 
added a 2M solution of K2CO3 (1 mL). The mixture was heated at indicated temperature 
(40-70 °C) under Ar for indicated duration of time (4-6 h). The reaction was diluted with 
water and extracted with DCM (25ml x 3). The combined organics were dried (Na2SO4) 
and concentrated and the resulting residue was subjected to flash silica chromatography 
(EtOAc/n-heptane). 
 
7.3.1    Synthesis of  2,3-diarylindenones 64a-g 
 
2,3-Diphenyl-1H-inden-1-one (64a). Compound 64a was prepared from 23 (144 mg,    
0.5 mmol) and phenylboronic acid (135 mg, 1.1 mmol), according to the 
General procedure A, as a  yellow crystalline solid (137 mg, 97 %). 
Reaction temperature: 70 °C. M. p. 154-155 °C. 1H NMR (300 MHz, 
CDCl3): δ = 7.04-7.07 (m, 1H, ArH), 7.16-7.22 (m, 6H, ArH), 7.30-7.34 (m, 
6H, ArH), 7.45--7.51 (m, 1H, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 121.3, 123.0, 127.7, 
128.1, 128.5, 128.8, 129.0, 129.3, 130.0 (CH), 130.8, 132.4, 132.7 (C), 133.4 (CH), 145.2, 
155.3 (C), 196.0 (CO). IR (KBr): v = 3381, 3070 (w), 1700, 1604, 1455, 1444, 1348, 1178, 
1157, 1149, 1081, 1065 (m), 1027, 1010, 999, 929, 918, 858, 840, 807 (w), 780, 760, 751, 
723, 699, 675 (s), 637, 612, 587, 549 (s), 1205, 1183, 1156, 1065, 1042 (m), 818, 742, 
701 (s), 617, 610, 587, 562, 537 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 282 ([M]+, 100), 
281 (82), 265 (16), 253 (39), 252 (47), 250 (18), 126 (12). HRMS (EI, 70 eV): calcd for 
C21H14O  [M]+: 282.10392; found: 282.10341. 
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2,3-Di-p-tolyl-1H-inden-1-one (64b). Compound 64b was prepared from 23 (144 mg    
0.5 mmol), p-tolylboronic acid (150 mg, 1.1 mmol), according to the 
General procedure A, as a yellow solid (154 mg, 99 %). Reaction 
temperature: 70 °C. M. p. 147-148 °C.  1H NMR (300 MHz, CDCl3):   
δ = 2.23 (s, 3H, CH3), 2.32 (s, 3H, CH3), 6.98-7.29 (m, 11H, ArH), 
7.46-7.49 (m, 1H, ArH). 13C NMR (75.5 MHz, CDCl3):  δ  = 21.3, 21.5 (CH3), 121.1,    
122.8 (CH), 128.0 (C), 128.5, 128.7, 128.9, 129.5, 129.9 (CH), 130.0, 131.0, 132.1 (C), 
133.3 (CH), 137.5, 139.4, 145.5, 154.8 (C), 196.8 (CO). IR (KBr): v = 3392, 3032, 2956, 
2921, 2865, 2770, 2734, 2677, 2143, 1915 (w), 1706, 1699 (s), 1605, 1595, 1583, 1502, 
1454, 1386, 1362, 1342, 1313, 1283, 1175, 1150, 1066, 1038, 1020, 1009, 973, 963, 949, 
922, 851, 824 (m), 806, 794 (s), 783 (m), 763, 727, 708 (s), 689, 644, 638, 623, 573,     
540 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 310 ([M]+, 100), 309 (21), 296 (15), 295 (62), 
293 (10), 266 (11), 265 (20), 263 (10), 252 (18). HRMS (EI, 70 eV): calcd for C23H18O  
[M]+: 310.13522; found: 310.13515. 
 
2,3-Bis(4-fluorophenyl)-1H-inden-1-one (64c). Starting with 23 
(144 mg, 0.50 mmol), Pd(PPh3)4 (29 mg, 5 mol-%), dioxane (5 mL), 
2M K2CO3 (1 mL) and 4-fluorophenylboronic acid (154 mg, 1.10 
mmol), according to the General procedure A, 64c was isolated as a 
brownish yellow solid (151 mg, 95 %). Reaction temperature: 70 °C 
for 6h. M. p. 134-   135 °C. 1H NMR (300 MHz, CDCl3):   = 6.85-6.94 (m, 2H, ArH), 7.01-
7.08 (m, 3H, ArH), 7.13-7.34 (m, 6H, ArH), 7.49-7.52 (m, 1H, ArH). 19F NMR (282.4 MHz, 
CDCl3):  = -113.0, -110.4 (ArF). 13C NMR (75.5 MHz, CDCl3):  = 115.3 (d, JC,F = 21.5 Hz, 
CH), 116.2 (d,   JC,F = 21.5 Hz, CH), 121.1, 123.2 (CH), 126.6 (d, JC,F = 3.4 Hz, C), 128.5 
(d,                   JC,F = 3.6 Hz, C), 129.2 (CH), 130.5 (d, JC,F = 8.3 Hz, CH), 131.5 (C),                  
131.8 (d, JC,F = 8.3 Hz, CH), 133.6 (CH), 144.9, 154.1 (C), 162.4 (d, JC,F = 248.4 Hz, CF), 
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163.2 (d, JC,F = 250.3 Hz, CF), 196.2 (CO). IR (KBr): v = 3070(w), 1705, 1592, 1575,   
1512 (m), 1498 (s), 1464, 1455, 1410, 1358, 1344, 1303 (m), 1221 (s), 1184 (s), 1159, 
1149, 1098, 1082, 1071, 1011, 924 (m), 861 (s), 838 (m), 824, 816, 794, 768, 733, 708 (s), 
680, 658, 641, 630, 572 (m), 541 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 318 ([M]+, 100), 
317 (53), 301 (14), 289 (19), 288 (36), 270 (11), 268 (12). HRMS (EI, 70 eV): calcd for 
C21H12 F2O [M]+: 318.08507; found: 318.08533. 
 
2,3-Bis(2-methoxyphenyl)-1H-inden-1-one (64d). Starting with 23 (144 mg, 0.50 mmol), 
Pd(PPh3)4 (5 mol-%), dioxane (5 mL), 2M K2CO3 (1 mL) and 2-
methoxyphenylboronic acid (167 mg, 1.10 mmol), according to the 
General procedure A, 64d was isolated as a brownish yellow solid   
(147 mg, 86 %). Reaction temperature: 70 °C for 6h. M. p. 121-122 °C. 
1H NMR (300 MHz, CDCl3):  = 3.42 (s, 3H, OCH3), 3.54 (s, 3H, OCH3), 6.72-6.91 (m, 5H, 
ArH), 7.01-7.28 (m, 6H, ArH), 7.44-7.48 (m, 1H, ArH). 13C NMR (75.5 MHz, CDCl3):           
 = 55.1, 55.2 (OCH3), 111.0, 111.1, 120.3, 120.5 (CH), 120.2 (C), 121.5, 122.5 (CH), 
123.0 (C), 128.3, 129.1, 129.2, 130.3 (CH), 131.0 (C), 131.1 (CH), 132.5 (C), 133.1 (CH), 
145.6, 154.8, 156.8, 157.4 (C), 196.2 (CO). IR (KBr): v = 3391, 3064, 2999, 2930,       
2833 (w), 1699, 1600, 1594, 1579, 1494, 1484, 1456, 1433, 1341, 1293, 1277 (m),     
1243 (s), 1177, 1161, 1126, 1109, 1072, 1045 (m), 1022 (s), 937, 924, 908, 855, 846,   
769 (m), 745, 733, 717 (s), 686, 671, 647, 633, 598, 566, 543, 535 (m) cm-1. GC-MS (EI, 
70 eV): m/z (%) = 342 ([M]+, 100), 312 (18), 311 (12), 281 (9), 255 (16), 252 (9), 239 (15), 
234 (16), 226 (10), 207 (10). HRMS (EI, 70 eV): calcd for C23H18O3 [M]+: 342.12559; 
found: 342.12558. 
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2,3-Bis(3-methoxyphenyl)-1H-inden-1-one (64e). Starting with 23 (144 mg, 0.50 mmol), 
Pd(PPh3)4 (5 mol-%), dioxane (5 mL), 2M K2CO3 (1 mL) and 3-
methoxyphenylboronic acid (167 mg, 1.10 mmol), according to the 
General procedure A, 64e was isolated as a brownish yellow solid   
(168 mg, 98 %). Reaction temperature: 70 °C for 6h. M. p. 83-84 °C.   
1H NMR (300 MHz, CDCl3):  = 3.57 (s, 3H, OCH3), 3.63 (s, 3H, OCH3), 
6.69-6.90 (m, 7H, ArH), 7.05-7.30 (m, 4H, ArH), 7.46- 7.50 (m, 1H, ArH).                          
13C NMR (75.5 MHz, CDCl3):  = 55.1, 55.3 (OCH3), 113.7, 114.1, 115.0, 115.1, 120.8, 
121.4, 122.5, 123.0, 129.0, 1291, 130.0 (CH), 130.7, 132.0, 132.3 (C), 133.5 (CH), 134.0, 
145.2, 155.4, 159.2, 159.8 (C), 196.3 (CO). IR (KBr): v = 3403, 3079, 3012, 2960, 2939, 
2916, 2843, 2831 (w), 1708 (s), 1606, 1595 (m), 1572 (s), 1476, 1454, 1446 (m), 1429 (s), 
1333, 1290 (m), 1280, 1231 (s), 1194, 1178, 1162 (m), 1128 (s), 1100, 1092, 1074 (m), 
1045 (s), 995, 969, 954, 903, 887, 878, 872, 846, 791 (m), 769 (s), 726, 708, 695, 683, 
675 (s), 626, 639, 599, 560, 542 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 342 ([M]+, 100), 
327 (11), 311 (21), 284 (10), 268 (12), 239 (17). HRMS (EI, 70 eV): calcd for         
C23H18O3 [M]+: 342.12505; found: 342.12429. 
 
2,3-Bis(4-methoxyphenyl)-1H-inden-1-one (64f). Starting with 23 (144 mg, 0.50 mmol), 
Pd(PPh3)4 (5 mol-%), dioxane (5 mL), 2M K2CO3 (1 mL) and 4-
methoxyphenylboronic acid (167 mg, 1.10 mmol), according to the 
General procedure A, 64f was isolated as a brownish yellow solid 
(166 mg, 97 %). Reaction temperature: 70 °C for 6h.                  
M. p. 94-95 °C. 1H NMR (300 MHz, CDCl3):  = 3.69 (s, 3H, OCH3), 3.75 (s, 3H, OCH3), 
6.72 (d, 2H, J = 8.9 Hz, ArH), 6.84 (d, 2H, J = 8.9 Hz, ArH),  7.06 (d, 1H, J = 7.2 Hz, ArH), 
7.12-7.18 (m, 3H, ArH), 7.22-7.28 (m, 3H, ArH), 7.42- 7.46 (m, 1H, ArH).                          
13C NMR (62.9 MHz, CDCl3):  = 55.2, 55.3 (OCH3), 113.7, 114.2, 121.0, 122.7 (CH), 
123.4, 125.1 (C), 128.6, 130.2 (CH), 131.0, 131.2 (C), 131.3, 133.3 (CH), 145.5, 153.8, 
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159.1, 160.3 (C), 196.9 (CO). IR (KBr): v = 3390, 3040, 3001, 2955, 2932, 2905, 2835, 
2542, 2251, 2023, 1892 (w), 1698, 1603 (s), 1514 (m), 1500 (s), 1454, 1441, 1343,     
1291 (m), 1244, 1173 (s), 1111, 1072 (m), 1026 (s), 922, 908, 855, 833, 819, 798, 785, 
766 (m), 733, 713 (s), 682, 656, 647, 631, 582, 560, 532 (m) cm-1. GC-MS (EI, 70 eV):  
m/z (%) = 342 ([M]+, 100), 327 (15), 226 (11). HRMS (EI, 70 eV): calcd for C23H18O3 [M]+: 
342.12505; found: 342.12509. 
 
2,3-Bis(3-fluorophenyl)-1H-inden-1-one (64g). Starting with 23 (144 mg, 0.50 mmol), 
Pd(PPh3)4 (5 mol-%), dioxane (5 mL), 2M K2CO3 (1 mL) and 4-
fluorophenylboronic acid (154 mg, 1.10 mmol), according to the General 
procedure A, 64g was isolated as a brownish yellow solid (152 mg,       
96 %). Reaction temperature: 70 °C for 6h. M. p. 124-125 °C.                        
1H NMR (300 MHz, CDCl3):  = 6.83-7.08 (m, 7H, ArH), 7.10-7.36 (m, 
4H, ArH), 7.49-7.52 (m, 1H, ArH). 19F NMR (282.4 MHz, CDCl3):  = -112.8, -111.3.       
13C NMR (75.5 MHz, CDCl3):  = 114.1 (d, JC,F = 21.3 Hz, CH), 114.4 (d, JC,F = 22.3 Hz, 
CH), 115.5 (d, JC,F = 21.1 Hz, CH), 115.8 (d, JC,F = 22.2 Hz, CH), 120.4, 122.4 (CH),  
123.2 (d, JC,F = 3.3 Hz, CH), 124.7 (d, JC,F = 3.0 Hz, CH),  128.5 (CH), 129.3 (C), 128.7 (d, 
JC,F = 8.4 Hz, CH), 130.6 (d, JC,F = 2.2 Hz, C), 129.8 (d, JC,F = 8.4 Hz, CH),                 
131.4 (d, JC,F = 8.3 Hz, C), 132.8 (CH), 133.4 (d, JC,F = 8.0 Hz, C), 143.5 (C),              
153.6 (d, JC,F = 1.9 Hz, C), 161.6 (d, JC,F = 245.2 Hz, C-F), 161.9 (d, JC,F = 247.5 Hz, C-F), 
194.5 (CO). IR (KBr): v = 3391, 3065, 2961, 2921, 2852 (w), 1702, 1610, 1598, 1580, 
1475, 1455, 1437, 1339, 1266, 1243, 1220, 1184, 1170, 1157, 1125, 1080, 1059, 973, 
930, 890, 859, 797 (m), 776, 763, 725, 706, 690 (s), 682, 670, 639, 596, 583,                
559 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 318 ([M]+, 100), 317 (49), 301 (14), 289 (30), 
288 (36), 270 (11), 268 (12). HRMS (EI, 70 eV): calcd for C21H12F2O [M]+: 318.08507; 
found: 318.08557. 
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7.3.2    Synthesis of 3-aryl-2-bromoinden-1-ones 65a-g 
 
2-Bromo-3-p-tolyl-1H-inden-1-one (65a). Compound 65a was prepared from              23 
(144 mg, 0.5 mmol), (PPh3)4Pd (0) (18 mg, 3 mol-%) and p-
tolylboronic acid (68 mg, 0.5 mmol), according to the General 
procedure A, as a  yellow solid (147 mg, 98 %). Reaction 
temperature: 45 °C. M. p. 100-101 °C. 1H NMR (300 MHz, CDCl3):  
δ = 2.37 (s, 3H, CH3), 7.08 (dt, 1H, J = 7.2, 1.0 Hz,  ArH), 7.18 (td, 1H, J = 7.9, 1.1 Hz, 
ArH), 7.24-7.29 (m, 3H, ArH), 7.45-7.51 (m, 3H, ArH). 13C NMR   (75.5 MHz, CDCl3):        
δ = 21.6 (CH3), 117.4 (C), 121.3, 123.6 (CH), 128.2 (C), 128.3, 128.9, 129.5 (CH),       
130.1 (C), 133.7 (CH), 140.8, 144.6, 157.0 (C) 189.9 (CO). IR (KBr): v = 3414, 3049, 3022, 
2919, 2856, 2141, 1911, 1748 (w), 1712 (s), 1607, 1599, 1569, 1557, 1504, 1451, 1362, 
1285, 1182, 1160, 1099, 1080, 1020, 1013, 918, 833, 826, 800, 776 (m), 755 (s), 719 (m), 
702 (s), 669, 629, 622, 596 cm-1. GC-MS (EI, 70 eV): m/z (%) = 300 ([M, 81Br]+, 98),      
298 ([M, 79Br]+, 100), 219 (37), 191 (21), 190 (18), 189 (50), 176 (13), 165 (9), 110 (9). 
HRMS (EI, 70 eV): calcd for C16H11BrO [M, 79Br]+: 297.99878; found: 297.99832. 
 
2-Bromo-3-(3,5-dimethylphenyl)-1H-inden-1-one (65b). Compound 65b was prepared 
from 23 (144 mg, 0.5 mmol), (PPh3)4Pd (0) (18 mg,  3 mol-%) and 
3,5-dimethylphenylboronic acid (75 mg, 0.5 mmol),  according to the 
General procedure A, as a  yellow solid (138 mg, 88 %). Reaction 
temperature: 45 °C. M. p. 136-137 °C. 1H NMR (300 MHz, CDCl3):  
δ = 2.32 (s, 6H, 2CH3), 7.03-7.29 (m, 6H, ArH), 7.43-7.46 (m, 1H, ArH).                  
13C NMR (75.5 MHz, CDCl3):  δ = 21.4 (CH3), 117.6 (C), 121.4, 123.5, 125.8, 128.9 (CH), 
130.0, 131.0 (C), 132.1, 133.7 (CH), 138.4, 144.7, 157.3 (C) 190.0 (CO). IR (KBr):          
v = 3412, 3072, 3009, 2959, 2913, 2856, 2731, 2677 (w), 1713 (s), 1600, 1553, 1455, 
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1374, 1361, 1309, 1285, 1227, 1185, 1104, 1080, 1015, 995, 959, 949, 905,  890, 859, 
844, 819, 801, 785 (m), 757 (s), 731 (m), 705, 668 (s), 640, 621, 547 (m) cm-1. GC-MS (EI, 
70 eV): m/z (%) = 314 ([M, 81Br]+, 99), 312 ([M, 79Br]+, 100), 233 (37), 205 (10), 203 (14), 
202 (19), 190 (15), 189 (43), 109  (10). HRMS (EI, 70 eV): calcd for C17H13BrO [M, 79Br]+: 
312.01443; found: 312.01477. 
 
2-Bromo-3-(2,6-dimethoxyphenyl)-1H-inden-1-one (65c). Compound 65c was prepared 
from 23 (144 mg, 0.5 mmol), (PPh3)4Pd (0) (18 mg, 3 mol-%) and 2,6-
dimethoxyphenylboronic acid (91 mg, 0.5 mmol), according to the 
General procedure A, as a  yellow crystalline solid (143 mg, 83 %). 
Reaction temperature: 40 °C. M. p. 189-190 °C. 1H NMR (250 MHz, CDCl3): δ = 3.71 (s, 
6H, 2OCH3), 6.58-6.68 (m, 3H, ArH), 7.05-7.18 (m, 2H, ArH), 7.22-7.34 (m, 2H, ArH).    
13C NMR (62.9 MHz, CDCl3): δ = 54.8 (2OCH3), 103.0 (CH), 107.8 (C), 120.1 (CH),    
120.6 (C), 121.8, 127.1 (CH), 128.3 (C), 129.8, 132.7 (CH), 144.3, 153.3, 156.7 (C),   
189.1 (CO). IR (KBr): v = 3009, 2965, 2934, 2836 (w), 1729, 1594, 1583, 1470, 1457, 
1441, 1423 (s), 1358, 1300 (w), 1290 (m), 1249 (s), 1189, 1169, 1151 (w), 1101, 1078, 
1028 (s), 952, 942, 918, 903, 873, 845 (w), 817, 800, 771, 756, 729, 721 (m), 703 (s), 667, 
650, 633, 614, 595, 577, 544 (w) cm-1. GC-MS (EI, 70 eV): m/z (%) = 346 ([M, 81Br]+, 43), 
344 ([M, 79Br]+, 44), 265 (13), 251 (18), 250 (100), 237 (16), 235 (17), 234 (16), 221 (9), 
207 (14), 165 (14), 163 (12), 151 (10). HRMS (EI, 70 eV): calcd for C17H13O3Br [M]+: 
344.00481; found: 344.00480. 
 
2-Bromo-3-(3-methoxyphenyl)-1H-inden-1-one (65e). Compound 65e was prepared 
from 23 (144 mg, 0.5 mmol), (PPh3)4Pd (0) (18 mg, 3 mol-%) and 3-
methoxyphenylboronic acid (76 mg, 0.5 mmol), according to the 
General procedure A, as a  yellow solid (138 mg, 88 %). Reaction 
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temperature: 45 °C. M. p. 108-109 °C. 1H NMR (300 MHz, CDCl3): δ = 3.80 (s, 3H, OCH3), 
6.96-       7.00 (m, 1H, ArH), 7.07-7.21 (m, 4H, ArH), 7.25-7.30 (m, 1H, ArH), 7.38 (t, J = 
7.9 Hz,  1H, ArH), 7.46-7.49 (m, 1H, ArH). 13C NMR (75.5 MHz, CDCl3): δ = 55.4 (OCH3), 
113.7,   116.0 (CH), 118.1 (C), 120.5, 121.3, 123.7, 128.9, 129.9 (CH), 132.4 (C), 133.8 
(CH), 144.5, 156.8, 159.7 (C) 189.8 (CO). IR (KBr): v = 3411, 3069, 3005, 2966, 2942, 
2217, 2839 (w), 1714 (s), 1603, 1593, 1584, 1374, 1563, 1483, 1462, 1453, 1427, 1365, 
1305, 1287, 1269 (m), 1234 (s), 1182, 1173, 1162, 1145, 1101, 1080 (m), 1030 (s), 993, 
964, 957, 888, 874, 866, 819, 822 (m), 793 (s), 780 (m), 758, 707, 699, 673 (s), 659, 644, 
614, 571, 549 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 316 ([M, 81Br]+, 100), 314 ([M, 
79Br]+, 100), 235 (31), 192 (10), 176 (12), 164 (27), 163 (38), 117 (10). HRMS (EI, 70 eV):      
calcd for C16H11BrO2 [M, 79Br]+: 313.99369; found: 313.99384. 
 
2-Bromo-3-(4-methoxyphenyl)-1H-inden-1-one (65f). Compound 65f was prepared from 
23 (144 mg, 0.5 mmol), (PPh3)4Pd (0) (18 mg, 3 mol-%) and 4-
methoxyphenylboronic acid (76 mg, 0.5 mmol), according to the 
General procedure A, as a  white yellow solid (139 mg, 88 %). 
Reaction temperature: 40 °C. M. p. 100-101 °C.                          
1H NMR (300 MHz, CDCl3): δ = 3.81 (s, 3H, OCH3), 6.97 (d, 2H, J = 8.8 Hz,  ArH), 7.09-
7.19 (m, 2H, ArH), 6.26 ( (td, 1H, J = 7.7, 1.3 Hz, ArH), 7.44-7.47 (m, 1H, ArH), 7.59 (d, 
2H, J = 8.9 Hz,  ArH),. 13C NMR (62.9 MHz, CDCl3):  δ = 54.4 (OCH3), 113.1 (CH),     
115.6 (C), 120.3 (CH), 122.3 (C), 122.4, 127.8, 129.1 (CH), 129.2 (C), 132.5 (CH), 143.4, 
155.5, 160.2 (C), 188.9 (CO). IR (KBr): v = 3412, 3080, 3064, 3043, 3016, 2968, 2953, 
2917, 2841,1747 (w), 1715, 1607, 1597 (s), 1577 (m), 1505 (s), 1468, 1455, 1445, 1417, 
1367, 1352, 1301 (m), 1258,1178 (s), 1113, 1098, 1078, 1028, 1011, 918, 830, 810,     
791 (m), 769 (s), 759, 724 (m), 704 (s), 667, 652, 624, 617, 576, 546 (m) cm-1. GC-MS (EI, 
70 eV): m/z (%) = 316 ([M, 81Br]+, 97), 314 ([M, 79Br]+, 100), 235 (15), 164 (24), 163 (38), 
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118 (10). HRMS (EI, 70 eV): calcd for C16H11BrO2 [M, 79Br]+: 313.99369; found: 
313.99354. 
 
2-Bromo-3-(3-fluorophenyl)-1H-inden-1-one (65f). Compound 65f was prepared from 
16 (144 mg, 0.5 mmol), (PPh3)4Pd (0) (18 mg, 3 mol-%) and 3-
fluorophenylboronic acid 23c (70 mg, 0.5 mmol), according to the General 
procedure A, as a yellow solid (125 mg, 83 %). Reaction temperature:     
45 °C. M. p. 116-117 °C. 1H NMR (300 MHz, CDCl3):  = 7.04-7.07 (m, 1H, 
ArH), 7.11-7.23 (m, 2H, ArH), 7.27-7.38 (m, 3H, ArH), 7.42-7.51 (m, 2H, ArH).                        
19F NMR (282.4 MHz, CDCl3):  = -111.3. 13C NMR (75.5 MHz, CDCl3):  = 115.3 (d,     
JC,F = 22.8 Hz, CH), 117.3 (d, JC,F = 21.8 Hz, CH), 118.8 (C), 121.1, 123.9 (CH), 124.1 (d, 
JC,F = 3.1 Hz, CH), 129.1 (CH), 129.7 (C), 130.6 (d, JC,F = 8.3 Hz, CH), 133.1 (d,            
JC,F = 8.2 Hz, C), 134.0 (CH), 144.2 (C), 155.5 (d, JC,F = 2.5 Hz, C), 133.1 (d, JC,F = 247.5 
Hz, C), 189.5 (CO). IR (KBr): v = 3425, 3080, 3054 (w), 1715 (s), 1596, 1580, 1565, 1484, 
1451, 1427, 1418, 1365, 1354, 1298, 1284, 1263, 1209, 1178, 1158, 1134, 1099, 1081, 
1071, 965, 893, 870, 824, 787, 765 (m), 710, 705, 700, 670 (s), 657, 640, 614, 599, 555, 
536 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 304 ([M, 81Br]+, 99), 302 ([M, 79Br]+, 100),   
224 (11), 223 (64), 195 (28), 194 (63), 175 (24), 169 (13), 168 (16), 112 (11), 97 (14). 
HRMS (EI, 70 eV): calcd for C15H9BrFO [M, 79Br]+: 302.98153; found: 302.98157. 
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7.3.3    Synthesis of  unsymmetrical 2,3-diarylindenones 66a-g 
 
General procedure B for One-pot sequential arylation 2,3-dibromo-1H-inden-1-one (66):  
In a pressure tube to a suspension of 2,3-dibromo-1H-inden-1-one 23 (288 mg, 1.0 mmol), 
tetrakis(triphenylphosphine)palladium (0) (35 mg, 3 mol-%) and Ar1B(OH)2 (1.0 mmol) in 
dioxane (5 mL) was added a 2M solution of K2CO3 (1 mL). The mixture was heated at 40-
45 °C under Ar for 6 h. Reaction was cooled to rt and added with 1.1 mmol of Ar2B(OH)2 
and tetrakis (triphenylphosphine) palladium (0) (35 mg, 3 mol-%). Reactions was heated 
under Ar for another 6h at 70 °C. After cooling the eactions to rt, reaction mixture was 
diluted with water and extracted with DCM (25ml x 3). The organics were dried (Na2SO4) 
and concentrated and the resulting residue was subjected to flash chromatography 
(EtOAc/n-heptane) which gave pure 66a-g. 
 
2-(4-Methoxyphenyl)-3-p-tolyl-1H-inden-1-one (66a). Compound 66a was prepared 
from 23 (288 mg, 1.0 mmol), p-tolylboronic acid (136 mg,             
1.0 mmol) and 4-methoxyphenylboronic acid (167 mg, 1.1 mmol), 
according to the General procedure B, as a  brown crystalline solid 
(303 mg, 93 %). Reaction temperature: 45 and 70 °C respectively. 
M. p. 115-116 °C. 1H NMR (250 MHz, CDCl3): δ = 2.41 (s, 3H, 
CH3), 3.80 (s, 3H, OCH3), 6.81 (d, J = 8.52 Hz, 2H, ArH), 7.12-7.21 (m, 1H), ArH), 7.14-
7.28 (m, 8H, ArH), 7.52-57 (m, 1H, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 21.5 (CH3), 
55.2 (OCH3), 113.6, 121.0, 127.7 (CH), 123.3 (C), 128.5, 128.6, 129.5 (CH), 130.0,    
130.9 (C), 131.3 (CH), 131.6 (C) 133.3 (CH), 139.3, 145.6, 154.0, 159.1 (C), 197.0 (CO). 
IR (KBr): v = 3387, 3042, 2999, 2937, 2843, 2548, 2368, 2335 (w), 1704, 1699 (s), 1596, 
1582, 1515, 1501, 1453, 1417, 1380, 1366, 1340, 1295 (m), 1251,  1176 (s), 1151, 1114, 
1068 (m), 1029 (s), 1006, 922, 850 (m), 831, 806, 798 (s), 775 (m), 764, 733 (s), 722, 713, 
680, 631, 575 (m), 555, 533 (s) cm-1. GC-MS (EI, 70 eV): m/z (%) = 326 ([M]+, 100),      
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311 (20), 268 (11), 239 (19). HRMS (EI, 70 eV): calcd for C23H18O2  [M]+: 326.130186; 
found: 326.13019. 
 
2-(3-Chlorophenyl)-3-p-tolyl-1H-inden-1-one (66b). Compound 66b was prepared from 
23 (288 mg, 1.0 mmol), p-tolylboronic acid (136 mg, 1.0 mmol) and 
3-chlorophenylboronic acid (172 mg, 1.1 mmol), according to the 
General procedure B, as a  white yellow solid (294 mg, 89 %). 
Reaction temperature: 45 and 70 °C respectively. M. p. 147-148 °C. 
1H NMR (300 MHz, CDCl3):  = 2.32 (s, 3H, CH3), 7.00-7.32 (m, 
11H, ArH), 7.50 (dd, 1H, J = 7.1, 0.6 Hz, ArH). 13C NMR (75.5 MHz, CDCl3):                  
 = 21.6 (CH3), 121.6, 123.0, 127.7, 128.1, 128.4, 129.2 (CH), 129.2 (C), 129.3, 129.6, 
129.9 (CH), 130.6, 130.8, 132.9 (C), 133.5 (CH), 133.9, 139.9, 144.9, 156.6 (C),         
195.9 (CO). IR (KBr): v = 3382, 3057, 3043, 3028, 2917, 2854, 2354, 2138, 2001,       
1938 (w), 1702 (s), 1606, 1595, 1575, 1563, 1509, 1505, 1454, 1403, 1340, 1311, 1300, 
1284, 1264, 1184, 1148, 1115, 1101, 1081, 1062, 1017, 998, 959, 921, 885, 854, 824,  
788 (m), 776, 767, 731, 726 (s), 716 (m), 693, 678 (s), 662, 601, 567, 558 (m) cm-1. GC-
MS (EI, 70 eV): m/z (%) = 332 ([M, 37Cl]+, 35), 330 ([M, 35Cl]+, 100), 317 (11), 315 (32), 
295 (42), 280 (14), 265 (19), 263 (14), 252 (27), 250 (13), 131 (9). HRMS (EI, 70 eV): 
calcd for C22H15ClO [M]+: 330.08059; found: 330.08018. 
 
3-(2,6-Dimethoxyphenyl)-2-(4-fluorophenyl)-1H-inden-1-one (66c). Starting with         
23 (288 mg, 1.00 mmol), Pd(PPh3)4 (35 mg, 3 mol-%),             
dioxane (5 mL), 2M K2CO3 (1 mL) and 2,6-dimethoxyphenylboronic 
acid (Ar1B(OH)2) (182 mg, 1.00 mmol), 4-fluorophenylboronic acid 
(Ar2B(OH)2) (154 mg, 1.10 mmol) and additional Pd(PPh3)4 (35 mg, 3 
mol-%), according to the General procedure B, 66c was isolated as a brownish yellow 
solid (309 mg, 86 %). Reaction temperature: 40 °C for 6h (1st step), 70 °C for 6h (2nd step). 
M. p. 206-207 °C. 1H NMR (300 MHz, CDCl3):  = 3.51 (s, 6H, 2OCH3), 6.53 (d, 2H,          
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J = 8.4 Hz, ArH), 6.68 (dt, 1H, J = 7.1, 0.8 Hz, ArH), 6.70-6.87 (m, 2H, ArH), 7.10-7.31 (m, 
5H, ArH), 7.43-7.46 (m, 1H, ArH). 19F NMR (282.4 MHz, CDCl3):  = -114.2.                  
13C NMR (75.5 MHz, CDCl3):  = 55.7 (2OCH3), 104.3 (CH), 110.5 (C), 114.7 (d,            
JC,F = 21.4 Hz, CH), 121.2, 121.3, 128.3  (CH),  128.5 (d, JC,F = 3.3 Hz, C), 1130.3 (d,    
JC,F = 8.0 Hz, CH), 130.4 (C), 130.9, 133.5 (CH), 145.8, 150.6, 157.8 (C), 162.1 (d,        
JC,F = 247.4 Hz, CF),  196.8 (CO). IR (KBr): v = 3046, 2963, 2931, 2838 (w), 1696, 1591, 
1581, 1574, 1504, 1471, 1462, 1455, 1442, 1432 (m), 1359, 1341, 1296 (w), 1255, 1222, 
1156 (m), 1109 (s), 1094, 1068, 1027, 1014 (m), 974, 960, 941, 925, 903 (w), 853, 825, 
794, 781 (m), 761, 731, 721, 709 (s), 684, 662, 643, 626 (w), 585, 550, 542 (m), 528 (s) 
cm-1. GC-MS (EI, 70 eV): m/z (%) = 360 ([M]+, 100), 273 (10), 257 (9), 172 (8). HRMS (EI, 
70 eV): calcd for C23H17FO3 [M]+: 360.11562; found: 360.11556. 
 
2-(2,6-Dimethoxyphenyl)-3-p-tolyl-1H-inden-1-one (66d). Compound 66d was prepared 
from 23 (288 mg, 1.0 mmol), p-tolylboronic acid (136 mg, 1.0 mmol) 
and 2,6-dimethoxyphenylboronic acid (200 mg, 1.1 mmol), according 
to the General procedure B, as a yellow crystalline solid (320 mg,     
90 %). Reaction temperature: 45 and 70 °C respectively. M. p. 207-
208 °C. 1H NMR (300 MHz, CDCl3):  = 2.26 (s, 3H, CH3), 3.49 (s, 6H, 2OCH3), 6.44 (d, 
2H, J = 8.3 Hz, ArH), 7.05 (d, 2H, J = 7.9 Hz, ArH), 7.12-7.29 (m, 6H, ArH), 7.45-7.48 (m, 
1H, ArH). 13C NMR (75.5 MHz, CDCl3):  = 21.1 (CH3), 55.8 (OCH3), 104.3 (CH),        
109.8 (C), 120.9, 122.6, 127.4, 128.4 (CH), 128.6 (C), 128.9, 129.7 (CH), 130.9, 132.0 (C), 
132.8 (CH), 139.0, 145.5, 157.4, 158.8 (C), 196.0 (CO). IR (KBr): v = 3390, 3077, 3025, 
2996, 2971, 2941, 2918, 2837, 2141 (w), 1704, 1673, 1604, 1580, 1530, 1470, 1455, 
1445, 1430,1360, 1332 (m), 1250 (s), 1180 (m), 1106 (s), 1062, 1030, 1017, 924, 855,  
817 (m), 765, 724 (s), 677, 657, 645, 604, 586, 561, 545 (m) cm-1. GC-MS (EI, 70 eV):                 
m/z (%) = 356 ([M]+, 100), 326 (27), 311 (17), 252 (10), 239 (12), 233 (34), 226 (9),       
119 (9). HRMS (EI, 70 eV): calcd for C24H20O3 [M]+: 356.14070; found: 356.13996. 
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3-(2-Methoxyphenyl)-2-p-tolyl-1H-inden-1-one (66e). Compound 66e  was prepared 
from 23 (288 mg, 1.0 mmol), 2-methoxyphenylboronic acid (152 mg, 
1.0 mmol) and p-tolylboronic acid (150 mg, 1.1 mmol),  according 
the General procedure B, as a yellow solid (277 mg, 85 %). 
Reaction temperature: 40 and 70 °C respectively. M. p. 157-158 °C. 
1H NMR (300 MHz, CDCl3):  = 2.21 (s, 3H, CH3), 3.52 (s, 3H, OCH3), 6.80 (dt, 1H,           
J = 7.2, 0.8, Hz, ArH), 6.87-6.97 (m, 4H, ArH), 7.09-7.34 (m, 6H, ArH), 7.44-7.47 (m, 1H, 
ArH). 13C NMR (75.5 MHz, CDCl3):  = 21.3 (CH3), 55.3 (OCH3), 111.6, 120.9, 121.3 (CH), 
122.4 (C), 122.5, 128.4, 128.7, 129.1, 129.8, 130.5 (CH), 130.6, 133.2 (C), 133.4 (CH), 
137.4, 145.8, 152.8, 157.0 (C), 196.9 (CO). IR (KBr): v = 3071, 3030, 3006, 2973, 2943, 
2917, 2841 (w), 1705, 1699, 1603, 1594, 1585, 1575, 1511, 1483, 1461, 1456, 1435, 
1344, 1293,1270 (m), 1245 (s), 1176, 1162, 1114, 1068, 1042, 1022, 982, 939, 922, 849, 
825, 791 (m), 761 (s), 745 (m), 725, 708 (s), 683, 665, 621, 549 (m) cm-1. GC-MS (EI,     
70 eV): m/z (%) = 326 ([M]+, 100), 295 (16), 252 (12), 239 (15). HRMS (EI, 70 eV): calcd 
for C23H18O2 [M]+: 326.13013; found: 326.13016. 
 
2-(4-Chlorophenyl)-3-(4-ethylphenyl)-1H-inden-1-one (66f). Compound 16f was 
prepared from 23 (288 mg, 1.0 mmol), 4-ethylphenylboronic 
acid (150 mg, 1.0 mmol) and 4-chlorophenylboronic acid     
(172 mg, 1.1 mmol), according to the General procedure B, as 
a yellow solid (272 mg, 79 %). Reaction temperature: 45 and  
70 °C respectively. M. p. 94-95 °C. 1H NMR (300 MHz, CDCl3): 
 = 1.21 (t, 3H, J = 7.61 Hz, CH3), 2.64 (q, 2H, J = 7.61 Hz, CH2), 7.12-7.33 (m, 11H, ArH), 
7.48-7.51 (m, 1H, ArH). 13C NMR (75.5 MHz, CDCl3):  = 15.2 (CH3), 28.8 (CH2), 121.5, 
123.0, 128.3, 128.4, 128.5, 129.1 (CH), 129.5, 129.6, 130.8 (C), 131.3, 133.5 (CH), 133.6, 
145.1, 146.0, 156.0 (C) 196.3 (CO). IR (KBr): v = 3393, 3026, 2963, 2930, 2872, 2676, 
2251, 2141, 1915, 1771 (w), 1704 (s), 1607, 1597, 1579, 1510, 1501 (m), 1487, 1455, 
1340, 1181 (s), 1089 (m), 1069, 1013 (s), 923, 908 (m), 858, 832, 814, 794, 764, 727, 715, 
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708 (s), 679, 648, 628, 574, 553, 542 (m) cm-1. GC-MS (EI, 70 eV): m/z (%) = 346 ([M+, 
37Cl], 35), 344 ([M+, 35Cl], 100), 317 (12), 315 (33), 309 (11), 280 (15), 265 (19), 263 (13), 
252 (16), 250 (9). HRMS (EI, 70 eV): calcd for C23H17ClO [M]+: 344.09624; found: 
344.09513. 
 
3-(3-Chlorophenyl)-2-p-tolyl-1H-inden-1-one (66g). Compound 66g was prepared from 
16 (288 mg, 1.0 mmol), 3-chlorophenylboronic acid (172 mg, 1.1 
mmol) and  p-tolylboronic acid (136 mg, 1.0 mmol), according to the 
General procedure B, as a  yellow solid (262 mg, 79 %). Reaction 
temperature: 45 and 70 °C respectively. M. p. 147-148 °C.                  
1H NMR (300 MHz, CDCl3):  = 2.22 (s, 3H, CH3), 6.96-7.00 (m, 3H, 
ArH), 7.05-7.32 (m, 8H, ArH), 7.46-7.49 (m, 1H, ArH). 13C NMR (75.5 MHz, CDCl3):            
 = 21.4 (CH3), 120.9, 123.2, 126.9 (CH), 127.3 (C), 128.3, 129.0, 129.3, 129.8,         
130.3 (CH), 130.5, 133.0 (C), 133.6 (CH), 134.7, 134.8, 137.7, 145.1, 152.8 (C),         
196.4 (CO). IR (KBr): v = 3058, 3024, 2918, 2860 (w), 1703 (s), 1601, 1590, 1558, 1337, 
1311, 1181, 1148, 1115, 1101, 1081, 1062, 1017, 998, 959, 921, 885, 854, 824, 788 (m), 
788, 723, 710, 700, (s), 716 (m), 693, 678 (s), 677, 640, 567, 553 (m) cm-1. GC-MS (EI, 70 
eV): m/z (%) = 332 ([M, 37Cl]+, 35), 330 ([M, 35Cl]+, 100), 315 (20), 295 (33), 280 (12), 265 
(19), 265 (18), 252 (27), 252 (31). HRMS (ESI+): calcd for C22H15ClO [M+H]+: 331.0884; 
found: 331.0883. 
O
Cl
Me
84 
84 
Appendix  
 
8   Crystallographic Data  
 
8.1 Crystal data and structure refinement for 2,3-bis(4-tert 
butylphenyl)benzofuran (58e) 
 
Identification code  tn6801 
Empirical formula  C28H30O 
Formula weight  382.52  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group (H.-M.)  P 21   
Space group (Hall)  P 2yb 
Unit cell dimensions a = 11.538 (11) Å α = 90°. 
 b = 17.067 (14) Å β = 114.199(18)°. 
 c = 12.504 (12) Å γ = 90°. 
Volume 2246 (4) Å3 
Z 4 
Density (calculated) 1.131 Mg/m3 
Absorption coefficient 0.066 mm-1 
F(000) 824 
Crystal size 0.90 x 0.30 x 0.18 mm3 
 range for data collection 6.2 to 58.2° 
Index ranges -16≤h≤16, -12≤k≤23, -17≤l≤17 
Reflections collected 23653 
Independent reflections 9998 [R(int) = 0.040] 
Absorption correction multi-scan 
Max. and min. transmission 0.988 and 0.943 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.030 
Final R indices [I>2(I)] R1 = 0.0510, wR2 = 0.1218 
R indices (all data)    R1 = 0.0804, wR2 = 0.1338 
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8.2 Crystal data and structure refinement for 2,3-bis(4-
chlorophenyl)benzofuran (58g) 
 
Identification code  tn6301 
Empirical formula  C20H12Cl2O 
Formula weight  339.20  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group (H.-M.)  P -1   
Space group (Hall)  -P 1 
Unit cell dimensions a = 6.0071 (3) Å α = 64.577°. 
 b = 11.043 (6) Å β = 88.917°. 
 c = 12.5267 (7) Å γ = 88.062°. 
Volume 794.99 (7) Å
3
 
Z 2 
Density (calculated) 1.421 Mg/m-3 
Absorption coefficient 0.410 mm-1 
F(000) 348 
 range for data collection 3.9 to 30.0°. 
Index ranges -8≤h≤7,  -16≤k≤16,  -17≤l≤17 
Reflections collected 3518 
Independent reflections 4478 [R(int) = 0.034] 
Absorption correction multi-scan 
Max. and min. transmission 0.968 and 0.697 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.091 
Final R indices [I>2(I)] R1 = 0.0436, wR2 = 0.1123 
R indices (all data) R1 = 0.0594, wR2 = 0.1209 
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8.3 Crystal data and structure refinement for 2,3-bis(4-
fluorophenyl)benzofuran (58h) 
 
Identification code  tn6601 
Empirical formula  C20H12F2O 
Formula weight  306.30  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  P 21 21 21   
Space group (Hall)  P 13c 13b 
Unit cell dimensions a = 6.0318 (12) Å α = 90°. 
 b = 11.417 (2) Å β = 90°. 
 c = 21.460 (4) Å γ = 90°. 
Volume 1477.9 (5) Å
3
 
Z 4 
Density (calculated) 1.377 Mg/m3 
Absorption coefficient 0.101 mm-1 
F(000) 632 
Crystal size 0.60 x 0.21 x 0.15 mm3 
 range for data collection 5.2  to59.1° 
Index ranges -4≤h≤8, -15≤k≤16, -27≤l≤30 
Reflections collected 9883 
Independent reflections 4274 [R(int) = 0.033] 
Absorption correction multi-scan 
Max. and min. transmission 0.985 and 0.942 
Refinement method Full-matrix least-squares on F2 
Goodness-of-fit on F2 1.056 
Final R indices [I>2(I)] R1 = 0.0411, wR2 = 0.0936 
R indices (all data) R1 = 0.0538, wR2 = 0.0985 
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8.4   Crystal data and structure refinement for 2-(4-fluorophenyl)-3-p-
tolylbenzofuran (13b) 
 
Identification code  tn9001 
Empirical formula  C21H15FO 
Formula weight  302.33  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group (H.-M.)  P b c a 
Space group (Hall)  P 13c  13b   
Unit cell dimensions a = 14.887 (14) Å α = 90°. 
 b = 10.191 (58) Å β = 90°. 
 c = 20.539 (18) Å γ = 90°. 
Volume 3116 (5) Å3 
Z 8 
Density (calculated) 1.289 Mg/m3 
Absorption coefficient 0.075 mm-1 
F(000) 1264 
Crystal size 0.60 x 0.21 x 0.15 mm3 
 range for data collection 5.2 to 59.1°. 
Index ranges -4≤h≤8, -15≤k≤16, -27≤l≤30 
Reflections collected 9883 
Independent reflections 3574 [R(int) = 0.033] 
Absorption correction multi-scan 
Max. and min. transmission 0.985 and 0.942 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.017 
Final R indices [I>2(I)] R1 = 0.0549, wR2 = 0.1357 
R indices (all data)    R1 = 0.0995, wR2 = 0.1525 
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8.5   Crystal data and structure refinement for 2,3-diphenyl-1H-inden-1-one 
(17a) 
 
Identification code  tn12301 
Empirical formula  C21H14O 
Formula weight  282.32  
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinbic 
Space group (H.-M.)  P 21/ n 
Space group (Hall)  P 2yn   
Unit cell dimensions a = 14.887 (14) Å α = 90°. 
 b = 10.191 (10) Å β = 110.201 (10)°. 
 c = 20.539 (18) Å γ = 90°. 
Volume 1492.8 (14) Å3 
Z 4 
Density (calculated) 1.256 Mg/m3 
Absorption coefficient 0.075 mm-1 
F(000) 592 
Crystal size 0.52 x 0.38 x 0.18 mm3 
 range for data collection 5.0 to 59.8° 
Index ranges -13≤h≤13, -23≤k≤23, -13≤l≤13 
Reflections collected 16734 
Independent reflections 4348 [R(int) = 0.022] 
Absorption correction multi-scan 
Max. and min. transmission 0.987 and 0.962 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.055 
Final R indices [I>2(I)] R1 = 0.0424, wR2 = 0.1087 
R indices (all data)    R1 = 0.0547, wR2 = 0.1149 
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8.6  Crystal data and structure refinement for 2-bromo-3-(2,6-
dimethoxyphenyl)-1H-inden-1-one (18c) 
 
Identification code  tn12703 
Empirical formula  C17H13BrO3 
Formula weight  345.18  
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system  Triclinbic 
Space group (H.-M.)  P 21/ n 
Space group (Hall)  P 1   
Unit cell dimensions a = 6.787 (5) Å α = 96.563 (12)°. 
 b = 9.279 (7) Å β = 98.53 (2)°. 
 c = 11.420 (8) Å γ = 98.921 (8)°. 
Volume 695.7 (8) Å3 
Z 2 
Density (calculated) 1.648 Mg/m3 
Absorption coefficient 0.075 mm-1 
F(000) 348 
Crystal size 0.45 x 0.30 x 0.08 mm3 
 range for data collection 5.4 to 60.0° 
Index ranges -9≤h≤9, -12≤k≤13, -16≤l≤14 
Reflections collected 14592 
Independent reflections 4035 [R(int) = 0.025] 
Absorption correction multi-scan 
Max. and min. transmission 0.798 and 0.349 
Refinement method Full-matrix  
Goodness-of-fit on F2 1.052 
Final R indices [I>2(I)] R1 = 0.0247, wR2 = 0.0616 
R indices (all data)    R1 = 0.0281, wR2 = 0.0625 
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Abbreviations  
 
Ac  Acetyl  
Anal.  Elemental Analysis  
bp.  Boiling point  
calcd  Calculated  
CI  Chemical Ionization  
COSY  Correlated Spectroscopy  
DEPT  Distortionless Enhancement by Polarization Transfer  
dr  Diastereomeric ratio  
ee  Enantiomeric excess  
EI  Electron Impact   
Et2O  Diethyl ether  
EtOH  Ethanol  
GC  Gas Chromatography  
GP  General Procedure  
HMBC Heteronuclear Multiple Bond Correlation  
HPLC  High Performance Liquid Chromatography  
HRMS High Resolution Mass Spectrometry  
IR  Infrared Spectroscopy  
MS  Mass Spectrometry  
mp  Melting point  
NaOEt Sodium ethanolate  
nBuLi  n-Butyllithium  
NEt3  Triethylamine  
NMR  Nuclear Magnetic Resonance  
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NOESY Nuclear Overhauser and Exchange Spectroscopy 
ORTEP Oak Ridge Thermal Ellipsoid Plot   
OTf  Triflate  
Ph  Phenyl  
ppm  Parts per million  
Rf  Retention factor  
Tf2O  Trifluoromethanesulfonic anhydride (triflic anhydride) 
TFA  Trifluoroacetic acid  
THF  Tetrahydrofuran  
TLC  Thin Layer Chromatography  
TMS   Tetramethylsilane  
Tol  Tolyl (p-MeC6H4)  
Tos  Tosyl (p-MeC6H4SO2
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